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The human innate immunity factor Apolipoprotein L-1 (APOL1) protects against 
Trypanosoma brucei brucei infection. Recent studies have shown recombinant APOL1 
(rAPOL1) inserts into planar lipid bilayers at an acidic pH 5.6 and forms a cation-selective 
channel, which opens upon subsequent neutralization, pH 7.2. This corresponds with the pH 
changes APOL1 would encounter during endosome recycling, suggesting that APOL1 forms a 
pH-gated ion channel in the plasma membrane of the parasite, leading to uncontrolled ion flux 
and osmotic imbalance. However, structural and domain characteristics of the APOL1 channel 
are poorly understood, despite potential similarities to diphtheria and colicin toxins. Utilizing E. 
coli-derived rAPOL1, we tested the effect of numerous site-directed substitutions on channel 
properties in planar lipid bilayers and in trypanoltyic assays. With this approach, we revealed 
that a single residue in the C-terminus, aspartate-348, influences channel selectivity and pH 
gating. Furthermore, we hypothesized that the C-terminal heptad repeat motif is required for 
oligomerization and channel formation. Indeed, specific amino acid substitutions in this domain  
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inhibit both channel formation and APOL1 mediated-trypanolysis. We then employed a scanning 
cysteine accessibility approach to elucidate membrane topology and transmembrane domains of 
the APOL1 channel. Taken together, these results highlight the importance of the C-terminus in 
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The APOL gene family 
   
The Apolipoprotein L 1-6 (APOL1-6) gene family is a cluster of rapidly evolving 
homologous proteins found in humans and other higher primates [1]. Located on a 619kD region 
on chromosome 22, they arose from a gene duplication event in primates approximately 33 
million years ago [2]. APOLs are all predicted to contain a Bcl-2 homology 3 (BH-3) domain, 
and thus could potentially lead to programmed cell death (PCD) pathways [3, 4]. Indeed, 
overexpression of APOL6 in HEK293 cells resulted in apopotosis of cancer cell lines [3]. The 
APOL proteins are also up regulated by the pro-inflammatory signaling molecules interferon-
alpha, interferon-beta, interferon-gamma and tumor necrosis factor, and have been under heavy 
positive selection during evolution [5-8]. Based on this evidence, the APOL family of proteins 
would appear to be innate immunity factors. In support of this notion, APOL6 has been indicted 
as a factor against Poliovirus, while APOL1 has been linked to ameliorating HIV infection in 
HEK293 cells and Leishmania sp. [9-12]The best-studied and understood example, however, is 
APOL1’s capacity to lyse African Trypanosomes both in vivo and in vitro [13-15]. However, 
studies propose the trypanolytic mechanism of APOL1 is dependent on its ability to form cation 




 African Trypanosomiasis is caused by the unicellular, flagellated parasites of the genus 
Trypanosoma, and presents both an economic and health burden to sub-Saharan Africa. 
Transmitted by the bite of an infected tsetse fly (glossina sp), the kinetoplastid has a complex 
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two-stage life cycle between its vertebrate hosts and invertebrate vector [17]. Although the 
species T. congolense, T. brucei brucei, and T. vivax are all causes of Animal African 
Trypanosomiasis (AAT), better known as nagana in cattle, T. congolense has been described as 
the most pathogenic [18]. Of note, some ~3-5 million cattle die as a result of infection, leading to 
an agricultural burden estimated to be ~$4 Billion USD annually [19]. However, only the sub-
species T. brucei rhodesiense and T. brucei gambiense are responsible for Human Africa 
Trypanosomiasis (HAT) in Eastern/southern and Western/Northern Africa, respectively [20]. At 
this time, T. b. rhodesiense infection remains a larger burden for humans lending to the acuteness 
of the infection and the large amount of wild/domestic animals acting as a reservoir[21]. 
Whereas improved awareness, diagnostic testing, and treatments has limited HAT by T. b. 
gambiense infection in recent years [22, 23]. In all, some ~20 million Africans are at risk for 
infection, with some ~20,000 cases occurring per year [24, 25]. 
 As previously mentioned, African Trypanosomes have a multistep lifecycle alternating 
between vector and host. The cycle initiates when a teneral tsetse fly takes its first blood meal 
from a previously infected mammal [26](10). During breakdown of the blood within the midgut 
of the tsetse fly, the trypanosomes subsequently transform into the procyclic state, where they 
can begin to multiply through binary fission [27](11). It then traverses the length of the tsetse fly 
until it reaches the salivary glands, but not before differentiating into the epimastigote form 
[27](11). Now residing in the salivary glands, the parasite reproduces asexually to generate 
additional epimastigotes while simultaneously differentiating into the mammalian infective, free-
swimming metacyclic form [27](11). Upon taking a blood meal, the fly deposits the 
trypanosomes into the tissues of the host, causing differentiating into the bloodstream form (BF) 
[28](12). The BF is then free to replicate in both the blood and tissues spaces until reaching a 
	3	
defined concentration threshold due to a recently defined quorum sensing mechanism [28](12). 
The parasites prepare to repeat their lifecycle by generating the stumpy induction factor 
assortment of soluble molecules, which initiates transformation into the non-replicating stumpy 
form to be taken up once again by a teneral tsetse fly [29]. 
The infective bloodstream form of the parasite is characterized by its long, slender shape 
and flagellum that transverses the entire length of the parasite ends at the anterior end [30]. At 
the posterior of the parasite resides the flagellar pocket, where the flagellum is anchored and all 
endocytic events take place (Figure 1) [31]. Uptake in the parasite is extremely rapid and 
efficient, as evidenced by the variable surface glycoprotein coat being recycled every 15 
minutes. [32]. Near the flagellar pocket resides the cytoplasmic kinetoplasmid, of which the 
parasite gets its class name (kinetoplastea), that houses small circular DNA plasmids encoding 
for all the mitochondrial genes [31]. Notably, the parasite only has a single mitochondrion, 
spanning the entire length of the organism; yet oddly glycolysis produces a majority of ATP 
required for cellular functions. Here, the mitochondrion serves as a site for processes including 
fatty acid synthesis and catabolism of amino acids for vital cellular processes [33, 34]. 
The most unique characteristic of the T. brucei parasite is the dense surface coat covering 
the entire length of the parasite. The specialized protein is termed Variable Surface Glycoprotein 
(VSG), and is GPI-anchored into the plasma membrane of the BF [35, 36]. Comprising nearly 
20% of all the protein expressed by the parasite, VSG forms a homodimer on the cell surface and 
presents a large antigenic target for circulating antibodies and other immune factors, while 
simultaneously blocking access to the limited receptors also present on the cell surface [37]. Due 
to their extraordinary rate of endocytosis, the parasites are rapidly able to clear any antibodies 
adhering to their VSG coat [38]. Furthermore, T. brucei are able to switch their VSG coat to one 
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expressed by one of 2000 unique genes by switching chromosome expression or by creating 
novel, “mosaic” VSG proteins through recombination of VSG genes [39, 40]. In this way, the 
Trypanosome can continually evade the adaptive immune system and successfully survive within 
the host. 
    
Trypanosome Lytic Factors 
 While African Trypanosomes can infect mammals, humans and other select primates 
have a natural resistance to infection. In 1984, a group observed that treating T. b. brucei with 
normal human serum (NHS) resulted in colloid osmotic swelling and eventual lysis in vitro [41]. 
Conversely, treating the parasites with an equivalent amount of rabbit serum had no effect on 
their growth or morphology. The authors then noted that supplementing the media with 0.25 M 
sucrose prevented the osmotic swelling and lysis of the trypanosomes when treated with NHS, 
potentially due to counterbalancing osmotic pressure within the parasite. Thus, further 
suggesting trypanolysis is owing to unregulated ion flux across the membrane leading to an 
influx of water and cell swelling. Previously, the trypanocidal factor was identified as the high-
density lipoprotein (HDL) fraction of human serum, although the mechanism of lysis was 
untested [42]. Additionally, it was later determined subset of HDL with a molecular weight of 
approximately ~500 kD was indeed the Trypanosome lytic factor (TLF) of human serum [43].   
The TLF complex comprises approximately 1% of total HDL, and exists as two forms in 
serum: TLF-1 and TLF-2 [43, 44]. The TLF-1 complexes is comprised of Apolipoprotein A-1 
(APOA-1), Haptoglobin Related Protein (HPR), Hemoglobin (Hb), Apolipoprotein L-1 (APOL1) 




Immunoglobulin-M (IgM) molecule potentially bound to Hpr, and is therefore ~1000 kD in size 
(Figure 2) [44]. The APOA-1 protein is primarily an amphipathic protein, and is able to form 
multimers with the purpose of acting as the structural scaffold of the HDL [45, 46]. The HPR 
and Hb proteins act as co-ligands for receptor- mediated endocytosis of TLF via the 
Trypanosoma brucei Haptoglobin Receptor (HpHbTbR) [47]. HPR arose from gene duplication 
of haptoglobin (Hp), which is normally complexed with Hb in blood and scavenged by the 
CD163 receptor on macrophages [48]. However, HPR has a four amino acid mutation in the loop 
recognized by CD163 and will therefore not be cleared from the blood [49]. This could serve a 
dual purpose: The lytic ability of TLF will not affect the macrophages and the TLF remains in 
the blood to continue its innate immune functions. The Apolipoprotein L-1 (APOL1) molecule is 
the main lytic component of human serum, and has recently been shown to be a pH-gated cation 
channel [13, 16].  
 
Trypanolysis by TLF 
African Trypanosomes are heme auxotrophs, and therefore must scavenge free heme 
from the blood to survive [50]. The TLF-1 complex, specifically the Hpr-Hb co-ligands, are 
thought to hijack this receptor, allowing for receptor-mediated endocytosis of TLF-1 at the 
flagellar pocket. [47]. Despite these findings, evidence suggests TLF-2 is the main lytic 
component of human serum. In vitro, adding physiological amounts of Hp to trypanolytic assays 
blocked killing by TLF-1, but not TLF-2 [44], suggesting Hp, which is typically at a 50-100 
higher fold concentration than Hpr in the blood, is able to out-compete TLF-1 for the receptor 
and thus limit receptor-mediated endocytosis [51]. To explain this result, it has been 




sail to concentrate the complex in the flageller pocket for fluid phase endocytosis [38]. 
Thisalternate route of entry implicates TLF-2, that may have a greater relevance to humans 
immunity to T. b. brucei than TLF-1.  
As detailed above, trypanolysis is dependent on the endocytosis of the entire TLF 
complex. [52].. Once endocytosed, the TLF was thought to traffic to the lysosome, where it 
becomes activated in the acidic environment (Figure 3). There, it leads to disruption of the 
lysosome, potentially due to APOL1 forming ion pores in the membrane [53-55]. In support of 
this model, the weak base ammonium chloride has been observed to inhibit TLF-mediated lysis 
due to neutralization of acidic compartments, thus preventing activation of APOL1 [56]. A 
second proposed model for TLF-mediated lysis is due to the generation of oxygen free radicals 
catalyzed by Hpr-Hb [57]. The free radicals then lead to peroxidation of lipids and lysosomal 
membrane disruption [51, 58]. However, this model is likely incorrect because human serum 
lacking Hpr retained lytic activity, albeit slightly delayed. Conversely, human serum from 
individuals lacking the APOL1 gene was completely devoid of any trypanolytic activity, which 
could be restored by supplementation recombinant APOL1 (rAPOL1) [59]. 
Treatment of trypanosomes with TLF leads to ion flux across the plasma membrane, 
similar to what was observed by Rifkin [41]. In particular, it is understood treatment with TLF 
leads to the influx of Na+ ions down their electrochemical potential gradient, followed by influx 
of Cl- ions into the cytoplasm of the parasite [55]. Due to the increase in osmotic potential within 
the parasite, excess water enters the cell resulting in swelling and eventual lysis. In support of 
this sequence of events, pre-incubation of T. b. brucei with TLF in vitro could only be delayed, 




ion. Conversely, replacement of Na+ with the larger choline+ ion had to coincide with the 
addition of TLF to prolong trypanolysis [55]. Additionally, treatment with 4,4’- 
diisothiocyanatostilbene-2,2’-disulfonic acid (DIDS), a general chloride channel blocker, is able 
to delay extracellular chloride influx after incubation with NHS [15]. Therefore, it would appear 
Na+ influx precedes Cl- influx, which could be explained by APOL1 channels at the cell surface. 
As mentioned earlier, the lytic component of TLF is the channel forming protein APOL1. 
This was first established when NHS was run on an anti-APOL1 affinity column, and 
successively testing the unbound sample in a trypanoltyic assay [13]. Unsurprisingly, it resulted 
in complete loss of activity in vitro. However, combining the elutant from the anti-APOL1 
column with the flow through restored trypanolytic activity [13]. Furthermore, adding back NHS 
devoid of APOL1 with recombinant APOL1 (rAPOL1) purified from Chinese Hamster Ovary 
(CHO) cells again restored lytic activity. Numerous other groups have confirmed this 
observation, as rAPOL1 from E. coli has been shown to traffic to the lysosome on its own and 
lyse trypanosomes in vitro [15, 60]. In addition, in vivo experiments testing mice transiently 
expressing the APOL1 protein via hydrodynamic gene delivery become immune to trypanosome 
infection [61]. Despite mounting research, the exact mechanism of APOL1-mediated lysis is 
unclear, and this motivated us to determine if the channel forming properties are directly 
involved. 
 
Function of Apolipoprotein L-1  
 Located on a 14.5kD segment of chromosome 22q13, the gene encodes for six 
introns and seven exons, resulting in the ~42kD protein [62]. The most common splice isoform, 
variant A, includes the signal peptide (exons 1, 3-4; 1-33), a domain of unknown function (exon 
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5-6; 35-105), while the remainder of the protein is coded in exons 6 and 7 (106-398) [63]. The 
signal peptide would allow for cellular trafficking through the endoplasmic reticulum (ER), 
leading to secretion of the protein and lending to the fact APOL1 is found on circulating HDL in 
the serum. While nearly 95% of all secreted APOL1 comes from the liver, numerous other 
tissues, including the neurons, intestines and kidneys, express basal levels of the mRNA 
transcript [1, 8, 64]. However, pro-inflammatory cytokines, including interferon-gamma and 
tumor necrosis factor, can result in a temporary up regulation of APOL1 [2]. Currently, the most 
well defined function studied for APOL1 is its ability to lyse African trypanosomes both in vivo 
and in vitro. Additionally, TLF has been shown to ameliorate Leishmania sp infection in 
humans, but it is currently unclear if this is a similar or different mechanism than with the 
Trypanosome sp. [11]. 
The trypanolytic activity of APOL1 can be attributed to its ability to form ion channels in 
lipid membranes. Under acidic conditions, rAPOL1 has demonstrated spontaneous insertion into 
both planar lipid bilayers and lipid vesicles made up of asolectin with or without cholesterol [16, 
65]. Within the bilayer system, this insertion resulted in relatively small conductance, which 
could not be washed away by perfusion, suggesting the protein was fully integrated into the 
membrane. Subsequent neutralization resulted in a large, ~3000-fold increase in the macroscopic 
conductance, potentially due to stabilization of the open channel state [16]. Titrating the solution 
back to pH 5.3 with HCl reduced the conductance back to pre-neutralization levels, which could 
be restored by addition of KOH to raise the solution to pH 7.2. The effect of pH on channel 
conductance was also observed in the lipid vesicle assays. When APOL1 was inserted into 
phospholipid vesicles at acidic pH 5, the ion efflux drastically increased when the extracellular 
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pH was raised to pH 7.0 [65]. Thus, the evidence presented here suggests APOL1 is indeed a pH-
gated ion channel, although the residue(s) responsible have yet to be determined. 
The same groups also addressed the selectivity of the APOL1 channel, and determined 
the channel to be selective for cations over anions. In order to test channel selectivity, Thomson 
and Finkelstein added increasing amounts of KCl to the cis solution after formation of a large 
macroscopic conductance, resulting in a cis/trans ion activity gradient (cis-closer to 
experimenter; trans-further from experimenter). By measuring the reversal potential required to 
zero ion flow, and comparing it to the theoretical Nernst potential, they determined rAPOL1 
channels were ideally cation selective [16]. They repeated this same experiment, but with sodium 
and chloride as the primary ions. Predictably, channels were ideally selective for sodium over 
chloride with this setup. In agreement with this result, an earlier paper assessing conductance 
caused by TLF at acidic pH detected cation selective ion movement across the membrane [55]. 
The ion flow was thought to be due to APOL1 on the TLF complex, however the cation 
permeability was not ideal. But, the difference in cis solution pH or bilayer phospholipids could 
account for this difference. The cation selectivity observed was then further supported in 
experiments with lipid vesicles in an extracellular milieu devoid of KCl [65]. After insertion and 
APOL1 channel formation, a chloride carrier (CI1) was added to the system to permit anion 
counter flow. If APOL1 were chloride selective, the resulting positive charge build up inside the 
vesicles would inhibit further ion efflux. Nevertheless, the authors detected a pH-dependent 
chloride efflux in the system, suggesting APOL1 was potassium permeant [65]. But it should be 
added the authors performed a chloride permease assay, in which case the potassium selective 
valinomycin would facilitate cation counter flux in the event APOL1 was anion selective. 
Interestingly, a large anion efflux from the vesicles was detected under these conditions. 
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Therefore, it would be pertinent to test the effect of various cis and trans pH values on APOL1 
ion channel selectivity.  
Taking into account the pH-gating and cation selectivity of APOL1, Thomson and 
Finkelstien offered a mechanism for APOL1 trypanolytic activity. They proposed that after 
endocytosis of the TLF complex, APOL1 inserted into the endosomal membrane under acidic 
conditions. At this point, the endocytic vesicle embedded with APOL1 could either traffic back 
to the plasma membrane or to the lysosome, the latter resulting in potential protein degradation 
by cathepsin-L [66, 67]. However, trafficking to the membrane could expose APOL1 to a neutral 
pH, resulting in formation of cation- selective pores at the cell surface. The resulting influx of 
sodium could result in membrane depolarization and chloride influx, causing osmotic swelling 
and lysis.  
A second model proposed implicates coupling of lysosomal and mitochondrial membrane 
permeabilization as the primary mediator of T. b. brucei lysis by APOL1 [60]. It was 
demonstrated that the TbKIFC1 kinesin trafficked rAPOL1 to the mitochondria, where it caused 
mitochondrial fenestration and release of TbEndoG endonuclease causing laddering of DNA. 
Additionally, rAPOL1 was observed to cause pores in the lysosome resulting in lysosomal 
swelling and membrane permeabilization, in agreement with the first papers identifying APOL1 
as the lytic component of TLF [13, 15, 60]. Despite this evidence, it should be noted an RNAi 
knockdown screen implicated different pathways for rAPOL1 and NHS-mediated lysis. In the 
case of rAPOL1, lysis was not affected by either p67 knockdown, or ICP and TbCATL 
depletion. Rather, NHS lytic activity was decreased in the first two conditions, and was increased 
in the case of TbCATL [68]. Based on this evidence, rAPOL1 may participate in several unique 
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death pathways, and all results with rAPOL1 should be recapitulated with NHS or TLF to 
corroborate findings.  
 
Molecular Arms Race 
Despite humans having TLF, and more precisely APOL1, we can still become infected 
with Trypanosoma brucei sp. In particular, the parasite T. brucei rhodesiense is able to 
completely evade TLF- mediated trypanolysis due to the presence of a single gene, termed 
Serum Resistance Associated factor (SRA) [69]. Notably, it has been shown to bind to the C-
terminus of APOL1 at acidic pH, thus preventing TLF-mediated lysis [14, 70, 71]. The SRA 
protein is a truncated homolog of the VSG gene, and is primarily localized to the endocytic 
pathway; with small amounts localizing to the flagellar pocket [13, 52, 72]. The protein structure 
is made up primarily of alpha helices, with the N-terminal transmembrane (TM) domains 1 and 2 
forming an anti-parallel coiled-coil. However, the third helix blocks the VSG dimerization 
interface, thus the protein exists as a monomer in solution and conserves the SRA-APOL1 
interaction site [73].  
Although T. b. rhodesiense is able to resist TLF lysis, T. b. gambiense is the species 
responsible for a majority of all HAT cases in Sub-Saharan Africa [22]. Currently, the 
mechanism of resistance to TLF by T. b. gambiense has yet to be elucidated, but several essential 
genes have been identified. The first of which is a single amino acid mutation in the TbHpHbR 
resulting in affinity loss for Hpr-Hb and therefore endocytosis of TLF [74]. However, we have 
already illustrated the distinct uptake mechanism of TLF-2; which is independent of this 
receptor, so it stands to reason this single mutation is only able to limit TLF-1 uptake into the 
cell. A second gene essential for resistance is the Trypanosoma brucei gambiense Specific Gene 
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(TgsGP), which is has been shown to stiffen membranes and resides in the endocytic pathway 
[75, 76]. We then expect APOL1 would be inhibited from inserting into the endosomal 
membrane at acidic pH, therefore limiting the number of APOL1 channels formed. But unlike 
SRA, expression of this single gene is insufficient for resistance. Finally, the acidic pH of the 
early endosome of T. brucei gambiense relative to other T. brucei sp. may allow for earlier 
activation of cysteine proteases and therefore enhanced APOL1 degradation [75]. Taken 
together, the resistance of T. b. gambiense to TLF appears to be multi-faceted, and dependent on 
collaboration between multiple resistance mechanisms. 
Possibly due to the evolution of these resistance mechanisms, there appears to be a 
molecular arms race between human APOL1 and African trypanosomes. In the last ~10,000 
years, two variants of APOL1 have arisen due to heavy positive selection [62]. The ancestral 
haplotype, termed G0, is also the most common allele worldwide. The genetic variants, G1 and 
G2, are defined by mutations in the C-terminal, SRA-interacting domain [77]. The G1 allele has 
2 missense mutations, at S342G and I384M, while the G2 variant has a 6 nucleic acid deletion 
resulting in deletion of N388/Y389. Both alleles confer resistance to T. brucei rhodesiense, 
despite G1 having a higher binding affinity to SRA than G2 [14, 77]. Interestingly, the I384M 
mutation lies in the SRA-APOL1-binding epitope, yet the S342G mutation confers partial 
resistance, suggesting an alternate mode of evasion other than reduced binding affinity. 
Conversely, the N388/Y389 deletion decreases binding affinity of APOL1 and SRA, thus 
allowing for trypanolysis and channel formation [14, 77]. Thomson and Finkelstein later 
supported this claim, and showed that pre-incubation of G0 rAPOL1 with rSRA had no effect on 
membrane insertion, but prevented channel opening upon neutralization [16]. However, pre-
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incubation of the G2 rAPOL1 with SRA had no effect on channel formation and the protein was 
able to still form a large macroscopic conductance.  
  
APOL1 Domains and Structure 
 While APOL1 has been well characterized as a pH-gated, cation channel, the domains 
lending to the functionality are currently unknown. The first paper characterizing the potential of 
APOL1 to form pores termed residues 60-235 the pore-forming domain, due to its putative 
structural similarity to pore-forming toxins as determined by the protein family motifs database 
(Pfam) (Figure 4) [15, 78, 79]. A peptide consisting of only the pore-forming domain was 
reconstituted in planar lipid bilayers, and an anion selective pore was observed at pH 5.5 [55]. 
Furthermore, when expressed in E.coli, the fragment could severely limit the colony-formation 
units, whereas a peptide of APOL1 missing N-terminal residues 60-235 did not affect colony 
growth[15]. Based on this evidence, the N-terminus has been deemed the pore forming domain 
throughout the literature, despite inability to identify the selectivity filter or pore-lining region. 
The region directly downstream of the supposed pore-forming domain, particularly 
residues 238-304, has been regarded as the membrane-addressing domain (Figure 4). Modeling 
of the region predicted it contained two amphipathic helices, suggesting it was capable of 
forming stable hydrophobic interactions [15]. To confirm this in silico finding, a synthetic 
peptide spanning amino acids L248-A291 was found to exhibit a high affinity for DOPC 
monolayers, comparable to that of known lipid-interacting peptides [15, 80]. Supporting this 
observation, compound substitutions of D249K/E253K/E256K prevented trypanolytic activity of 
the full-length protein. Therefore, it was assumed the charged aspartate residues in this region 
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interact with the choline head groups of the phospholipids in the endocytic pathway, promoting 
APOL1 pore formation. 
The C-terminus of APOL1 has conflicting reports in regards to function throughout the 
literature. The first study that determined APOL1 was the lytic component of human serum  
concluded the C-terminus was not necessary for Trypanoltyic activity. After depletion of APOL1 
from NHS with SRA, an add back of a C-terminal truncation (del343-398) purified from CHO 
cells was sufficient for lysis of trypanosomes sensitive to NHS [13]. In contrast to this finding, 
planar lipid bilayer experiments of a truncated APOL1 lacking residues 341-398 were unable to 
form any conductance at acidic pH or upon subsequent neutralization [16]. Additionally, 
rAPOL1 deficient of the final nine amino acids did not have any effect on trypanolytic activity 
[71]. Considering all this conflicting information, it is difficult to conclude the importance of the 
C-terminus to channel formation and/or trypanolytic activity. The only consensus within the 
literature is the C-terminus is the site of interaction with the SRA protein. Surface plasmon 
resonance of C-terminal peptides of APOL1 showed strong binding to SRA at acidic conditions, 
while numerous groups have reported pull-down of either SRA or APOL1 in co-
immunoprecipitations [14, 71]. Taking into account SRA is solely responsible for inhibition of 
APOL1- mediated trypanolysis of T. b. rhodesiense, it appears likely the C-terminus is necessary 
for channel formation. 
 Despite the numerous studies on APOL1, minimal data concerning the structure has been 
elucidated. In silico analysis of APOL1 secondary structure utilizing the PROFSec server 
calculates three putative transmembrane domains and a coiled-coil in the C-terminus due to a 
heptad repeat motif [14]. However, none of these transmembranes has been either confirmed or 




yielded a potential three-dimensional model of the APOL1 channel. Employing the I-TASSER 
online server and the known structures of various proteins, the APOL1 channel was predicted to 
have five transmembrane domains, with residues S342, I384 and Y389 all involved in pore 
formation [81]. Interestingly, these are the site-specific mutations found in G1 (amino acids 
342/384) and G2 (amino acid 389). Notwithstanding, there is again no biochemical evidence 
presented in this report or in the literature that supports this model.  
   
Pore Formation of Bacterial Pore-Forming Toxins 
 The diphtheria toxin (DpTx) created by the gram-positive bacillus Corynebcaterium 
diphtheria is able to form single channel cation conductance in planar lipid bilayers. Although 
the full protein is 535 amino acids and made up of the C, T and R domains, only the T domain 
has channel activity [82]. Additionally, only a 61 amino acid peptide of the T domain is required 
for single channel conductances [79]. This fragment corresponds to transmembrane helicies 8 
and 9 in the crystal structure, which forms an alpha helical hairpin, similarly predicted for 
APOL1 [83]. The peptide is able to insert into the membrane at a cis acidic and trans neutral pH, 
and the channel conductance is increased upon cis solution neutralization [84, 85]. These 
conditions are similar to that required for the APOL1 channel, but the pH dependence of 
conductance is not as stark. In addition, the 61 amino acid fragment contains three glutamate 
residues near the pore, two of which are directly involved in channel conductance (D352 and 
D362) [84, 86, 87]. Although the D362 residue lies within the pore itself, only the D352 residue 
has a significant effect on ion selectivity. Furthermore, the D352 residue accounts for all of the 
trans pH effect on conductance, implicating that the residue is located near or at the trans 
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membrane [85]. Considering APOL1 also has three glutamate residues in the predicted hairpin 
(177-228), it in our best interest to test if APOL1 has similar properties to that of DpTx.  
 Comparable to DpTx, the colicin Ia bactericidal protein is able to form voltage-
dependent, ion-conducting channels in lipid membranes [88]. A three-domain protein, only the 
C-terminal channel-forming domain is necessary for ion conductance. Accordingly, a 40 amino 
acid hydrophobic hairpin connected by a small loop within this region is responsible for 
membrane association and insertion, which is especially favored at low pH [78]. The process 
begins with the hairpin resting horizontally on the membrane surface, and the loop being 
exposed to the cis solution. The hairpin can then spontaneously insert into the membrane, 
although reversibly, exposing the loop to the trans solution. However, a cis positive voltage 
(~50-70 mV) is required for translocation of a second segment necessary for ion conductance 
[89]. While APOL1 does not exhibit any dependence on the voltage for ion conductance, the 
membrane insertion of the hairpin and secondary fragment may be relevant to APOL1 channel 
formation.  
 
General Ion Channel Architecture 
The general function of ion channels is to form a pore in biological membranes to allow 
for the regulated passage of ions through the hydrophobic core of phospholipids down their 
electrochemical potential. To accomplish this undertaking, ion channels have two basic 
functions: to control the passage of select ions across a membrane, and to respond to specific 
stimuli in the environment that shifts the channel between the open and closed states [90]. More 
specifically, ion channels have conserved and/or typical selectivity filters that are able to 
distinguish between cations or anions (ex: non-selective cation channels), and even between 
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monovalent ions (ex: voltage-gated sodium or potassium channel) [91] [92]. Furthermore, the 
channels can respond by either opening or closing to a range of inputs, including ligands, 
voltage, temperature and even mechanical force. And opening of these channels permits up to 
108-9 molecules/second to flux through the open pore [93]. While there are numerous classes of 
these channels, the superfamily of voltage-gated potassium channels (VGKC) is one of the best  
studied, and will be further focused on in order here to generate a better understanding of the ion 
channel structure-function relationship.  
Regarding the general architecture of the VGKC domains, they have three distinct 
domain regions (Figure 5A). The first is the pore-forming domain, which consists of 
transmembrane helices that span the length of the membrane. These helices form the pore itself, 
and thus allow passage of ions through the normally inpermeant membrane [94]. The second 
domain common to VGKCs is the transmembrane component that is able to sense changes in 
voltage. Normally, this domain is identified by numerous positive charges, namely arginine 
residues, which cause a conformation change upon sensing a change in the voltage of the system, 
therefore opening or closing the pore [95]. Finally, the third domain reminiscent of VGKCs is 
the intracellular regions that are responsible for various functions. Namely, binding to ligands 
and structuring the channel through interactions that lead to the higher order oligomeric state of 
the channel [96]. 
The overall architecture of the functional ion channels, specifically VGKCs, includes 
helical domains that transverse the membrane and contribute to a central pore. Thus, these 
channels are defined as integral membrane proteins. While some channels only have two 







either four (2-pore potassium channels), six (Kv1.2) or seven (Ca2+ activated potassium 
channels) transmembrane domains per subunit. (Crystal structure and mechanism of a calcium- 
gated potassium channel. [97] [98] [99] [100]. Despite this difference, all of these channels form 
multimers as a functional protein. Interestingly, the VGKCs form symmetrical tetramers as the 
functional channel, with each subunit contributing two transmembrane helices to the cylindrical 
pore in what is termed as the “barrel stave” model (Figure 5B) [101]. The remaining 
transmembrane helices, if present, help to stabilize this central pore. However, it is worth noting 
other channels in various families appear as dimers (chloride channels), pentamers (nicotinic 
acetylcholine receptor) and trimers (mechanosensitive channels). Despite these differences in 
multimerization ion channels appear to possess some degree of oligomerization, which may be 
relevant to APOL1 structure [102] [103] [104]. 
The ability of ion channels to have a preference for certain ions over others is due in part 
to the selectivity filter. This highly conserved region is able to distinguish between cations and 
anions, and even more incredibly the monovalent cations sodium and potassium. For instance, 
the voltage gated potassium channels have a fidelity of nearly 10,000:1 for potassium over 
sodium because of the pore loop, an intramembrane loop that exists between the pore forming 
transmembrane domains and acts as the selectivity filter [93]. In the six transmembrane family of 
VGKCs, this would be between helices five and six [105]. The highly conserved repeat of 
TVGYG in the pore loop allows for the carboxyl backbone of the amino acids to coordinate with 
the dehydrated potassium ion in an energetically favorable conformation [106]. Whereas the 
smaller, but less energetically favorable, sodium ion is largely excluded from passing through the 
channel. In the case of the voltage gated sodium channels and calcium channels, which have a 
similar architecture to the VGKCs, they both have unique selectivity filters that help to exclude 
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the incorrect ions. The voltage gated sodium channels, for instance, contain either an EEEE 
(bacterial NaV) or DEKA (mammalian NaV) ring that selects for the smaller sodium ion in a 
partially hydrated state and excludes the potassium ion [107]. Similarly, the calcium channels 
utilize rings of negatively charged residues, but in this instance aspartate, as crucial ion binding 
sites necessary for Ca2+ selectivity [108].  
 
Kidney Disease and APOL1 
 Briefly, APOL1 has been associated with non-diabetic kidney disease in individuals with 
recent African Ancestry. Specifically, individuals possessing two copies of the renal risk variants 
G1 or G2 are at increased lifetime risk for developing focal segmental glomerulosclerosis, 
hypertension-associated end stage kidney disease and HIV-associated nephropathy [77, 109, 
110]. With an estimated 5 million African Americans at risk, the mechanism by which APOL1 
leads to cytotoxicity is a strongly debated topic in the field [111]. Current mechanisms leading to 
cell toxicity by the renal risk variants include altered localization to lipid droplets, stimulation of 
the NLRP3 inflammasome, and opening of the mitochondrial permeation pore [81, 112, 113]. 
Unbelievably, all of these pathways have been proposed in just the past year. While we are not 
directly addressing the role of APOL1 in kidney disease, we hope the work presented here can 









- What is the effect of pH on APOL1 ion selectivity? 
- Identification of the pore lining region? 
- What residue(s) contribute to ion selectivity? 
 
Chapter 2 
- Are the C-terminal leucine residues dispensable for APOL1 channel function? 
- Does disruption of the putative coiled-coil prevent channel formation? 
- Can APOL1 form oligomers in solution? 
 
Chapter 3 
- What is the effect of proteases on the APOL1 Channel? 
- How many transmembrane domains exists in the APOL1 Channel? 















For bacterial expression of recombinant APOL1, the pNIC28 vector containing an N-
terminal 6x His-tagged, G0 APOL1 (aa 28-398, accession no. O14791) was gifted by Russell 
Thomson. All substitutions were performed by site-directed mutagenesis of the pNIC28 APOL1 
(QuikChange II, Agilent Technologies). The protocol was precisely followed according to the 
manufacturers specifications. But briefly, ~25 ng of plasmid DNA was mixed with 125 ng of 
forward and reverse primers (see list below), dNTPs and reaction buffer. The PfuUltra DNA 
polymerase (Agilent, 600850) allowed for new plasmid synthesis during 18 cycles in a Bio-Rad, 
C1000 Touch Thermal Cycler. Template DNA was then digested with Dpn1 (Agilent, 500402) 





5’ – GGGTCCATGGTGCAAGCAGCCCAGTC 
3’ – GACTGGGCTGCTTGCACCATGGACCC 
 
APOL1 I68C 
5’ – GAAATACTTAATGGCATCCTCGCAAAAGATACTGCTCTCTGGGTCCATG – 3’ 
3’ – CATGGACCCAGAGAGCAGTATCTTTTGCGAGGATGCCATTAAGTATTTC – 5’ 
 
APOL1 K78C 
5’ – GCAGATTCTGTGTGCTCACGCATTCCTTGAAATACTTAATGGC 
ATCCTCAATAAAG – 3’ 
3’ – CTTTATTGAGGATGCCATTAAGTATTTCAAGGAATGCGTGAGCAC 
ACAGAATCTGC – 5’ 
 
APOL1 L88C 
5’ – GTTCCAGGCCTCATTATCAGTGCACAGGAGTAGCAGATTCTGTGT – 3’ 
3’ – ACACAGAATCTGCTACTCCTGTGCACTGATAATGAGGCCTGGAAC – 5’ 
 
APOL1 V98C 
5’ – GCAGTTCAGCAGCAGCGCAGAATCCGTTCCAGGCC – 3’ 
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3’ – GGCCTGGAACGGATTCTGCGCTGCTGCTGAACTGC – 5’ 
 
APOL1 A108C 
5’ – GAGCTTTACGGAGCTCATCGCACTCATTCCTGGGCACTTCA – 3’ 
3’ – TGAAGTGCCCAGGAATGAGTGCGATGAGCTCCGTAAAGCTC – 5’ 
 
APOL1 L118C 
5’ – TTCATGATCATTTGTCTTGCACAGTTGTCCAGAGCTTTACGGAG – 3’ 
3’ – CTCCGTAAAGCTCTGGACAACTGTGCAAGACAAATGATCATGAA – 5’ 
 
APOL1 N128C 
5’ – GCCTTTATCGTGCCAGCATTTGTCTTTCATGATCATTTGTCTTGCA – 3’ 
3’ – TGCAAGACAAATGATCATGAAAGACAAATGCTGGCACGATAAAGGC – 5’ 
 
APOL1 F140C 
5’ – CAGCAGTACAGAAACTGGTGTCTGAAAGAGTTTCCTCGGTTGAAAAG – 3’ 
3’ – CTTTTCAACCGAGGAAACTCTTTCAGACACCAGTTTCTGTACTGCTG – 5’ 
 
APOL1 K148C 
5’ – CTTCTTATGTTATCCTCAAGCTTACTGCACAACCGA 
GGAAACTCTTTCAGAAACC – 3’ 
3’ – GAAGAATACAATAGGAGTTCGAATGACGTGTTGGCTCC 
TTTGAGAAAGTCTTTGG – 5’ 
 
APOL1 L158C 
5’ – CCATCTGCAAGGGCACGGCACCTTCTTATGTTATCCTCA – 3’ 
3’ – GGTAGACGTTCCCGTGCCGTGGAAGAATACAATAGGAGT – 5’ 
 
APOL1 V168C 
5’ – TGGTGGTGCCTTTGTGGCACTTCTGAACCCCATCTG – 3’ 
3’ – ACCACCACGGAAACACCGTGAAGACTTGGGGTAGAC – 5’ 
 
APOL1 V178C 
5’ – AAATGCTGAGAGAGCCAGAGCACACATTGGCGATGGTGGTG – 3’ 
3’ – TTTACGACTCTCTCGGTCTCGTGTGTAACCGCTACCACCAC – 5’ 
 
APOL1 I188C 
5’ – CCGACGAGGGTCAGGCAGCCAGAGGAAATGCT – 3’ 
3’ – GGCTGCTCCCAGTCCGTCGGTCTCCTTTACGA – 5’ 
 
APOL1 F199C 
5’ – GGTCTGGCACCCTGCACAGAGGGAGGCAGCCTTGTACTCTTG – 3’ 
3’ – CAAGAGTACAAGGCTGCCTCCCTCTGTGCAGGGTGCCAGACC – 5’ 
 
APOL1 E201C 
5’ – AAGGCTGCCTCCACATGTGAAGGGTGCCAGACCCATGC – 3’ 
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3’ – TTCCGACGGAGGTGTACACTTCCCACGGTCTGGGTACG – 5’ 
 
APOL1 L208C 
5’ – CAACTCCATCCCAGGTTCGCAGAGTACAAGGCTGCCTC – 3’ 
3’ – GTTGAGGTAGGGTCCAAGCGTCTCATGTTCCGACGGAG – 5’ 
 
APOL1 T217C 
5’ – GGGATGGAGTTGGGAATCTGCGCAGCTTTGACCGGGATT – 3’ 
3’ – CCCTACCTCAACCCTTAGACGCGTCGAAACTGGCCCTAA – 5’ 
 
APOL1 A228C 
5’ – CACCACTTCTTTCCGTAGTCGCAGGTACTGCTGGTAATCCCGG – 3’ 
3’ – GTGGTGAAGAAAGGCATCAGCGTCCATGACGACCATTAGGGCC – 5’ 
 
APOL1 A238C 
5’ – GGTCGTGGGCTTGGCATTGTGTCCACCACTTCT – 3’ 
3’ – CCAGCACCCGAACCGTAACACAGGTGGTGAAGA – 5’ 
 
APOL1 V244C 
5’ – TTGTCAAGGCTTTTGATGCACAGGTCGTGGGCTTGGG – 3’ 
3’ – AACAGTTCCGAAAACTACGTGTCCAGCACCCGAACCC – 5’ 
 
APOL1 L248C 
5’ – CACCTCCTTCAATTTGTCACAGCTTTTGATGACCAGGTCG – 3’ 
3’ – GTGGAGGAAGTTAAACAGTGTCGAAAACTACTGGTCCAGC – 5’ 
 
APOL1 L258C 
5’ – GTTGGATATGTTCTCACCGCAAAACTCCTTCACCTCCTTCAATT – 3’ 
3’ – CAACCTATACAAGAGTGGCGTTTTGAGGAAGTGGAGGAAGTTAA – 5’ 
 
APOL1 L268C 
5’ – GGTGAGAACATATCCAACTTTCTTTCCTGTGCTGGCAATACTTAC – 3’ 
3’ – CCACTCTTGTATAGGTTGAAAGAAAGGACACGACCGTTATGAATG – 5’ 
 
APOL1 G278C 
5’ – TGTCCTTCCCAATGCATCGTGTGAGTTGGTAAGTA – 3’ 
3’ – ACAGGAAGGGTTACGTAGCACACTCAACCATTCAT – 5’ 
 
APOL1 R288C 
5’ – CCTTCCCAATGCCACATTGAGTTGGTAAGTATTGCCAGCT – 3’ 
3’ – GGAAGGGTTACGGTGTAACTCAACCATTCATAACGGTCGA – 5’ 
 
APOL1 H298C 
5’ – GCGTGAGGCTGAGGCACACGGTACTGACTGAAGA – 3’ 




5’ – TTGGCTCAGTGACGCAGGGGGCGTGAGGCT – 3’ 
3’ – AACCGAGTCACTGCGTCCCCCGCACTCCGA – 5’ 
 
APOL1 E328C 
5’ – GAGCTTGACTCCTCTGCTCATGGACAGGATGCTGGGTTCATTAAC – 3’ 
3’ – CTCGAACTGAGGAGACGAGTACCTGTCCTACGACCCAAGTAATTG – 5’ 
 
APOL1 V338C 
5’ – GAAGCTTACAGGGGCGCAATCCGTGAGCTTGACTCCTCTG – 3’ 
3’ – CTTCGAATGTCCCCGCGTTAGGCACTCGAACTGAGGAGAC – 5’ 
 
APOL1 V346C 
5’ – GTAGACTACATCCAGACAAAGAAAGAACCTTACAGGGGCCACATCC – 3’ 
3’ – CATCTGATGTAGGTCTGTTTCTTTCTTGGAATGTCCCCGGTGTAGG – 5’ 
 
APOL1 D348C 
5’ – CGTACACGAGGTAGACTACACACAGCACAAGAAAGAAGCTTA – 3’ 
3’ – GCATGTGCTCCATCTGATGTGTGTCGTGTTCTTTCTTCGAAT – 5’ 
 
APOL1 A363C 
5’ – TCCTAGCTGTCTCTGACTTGCACCCCTCATGTAAGTGCTTTG – 3’ 
3’ – AGGATCGACAGAGACTGAACGTGGGGAGTACATTCACGAAAC – 5’ 
 
APOL1 K373C 
5’ – TCCAGCTCCTGAGCCACACACTTCAGCTCCTCAGCTG – 3’ 
3’ – AGGTCGAGGACTCGGTGTGTGAAGTCGAGGAGTCGAC – 5’ 
 
APOL1 A375C 
5’ – CTCCTCCAGCTCCTGACACACCTTCTTCAGCTCC – 3’ 
3’ – GAGGAGGTCGAGGACTGTGTGGAAGAAGTCGAGG – 5’ 
 
APOL1 N387C 
5’ – CCGCCTGCAGAATCTTATAATTACAGTTGAGAATGTTTAGCTTCTCCT – 3’ 
3’ – GGCGGACGTCTTAGAATATTAATGTCAACTCTTACAAATCGAAGAGGA – 5’ 
 
APOL1 D337N 
5’ – TTACAGGGGCCACATTCGTGAGCTTGACTCC – 3’ 
3’ – AATGTCCCCGGTGTAAGCACTCGAACTGAGG – 5’ 
 
APOL1 D348N 
5’ – GCTTCTTTCTTGTGCTGAATGTAGTCTACCTCGTG – 3’ 
3’ – CGAAGAAAGAACACGACTTACATCAGATGGAGCAC – 5’ 
 
APOL1 D348H 
5’ – CACGAGGTAGACTACATGCAGCACAAGAAAGAAGC – 3’ 
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3’ – GTGCTCCATCTGATGTACGTCGTGTTCTTTCTTCG – 5’ 
 
APOL1 LZA 1 (First) 
5’ – CTGAGCCACCTTCTTCGCCTCCTCAGCTGTCTCT – 3’ 
3’ – AGAGACAGCTGAGGAGGCGAAGAAGGTGGCTCAG – 5’ 
 
APOL1 LZA 2 (On LZA 1 plasmid) 
5’ – GTTTAGCTTCTCCTCCGCCTCCTGAGCCACCTTC – 3’ 
3’ – GAAGGTGGCTCAGGAGGCGGAGGAGAAGCTAAAC – 5’ 
 
APOL1 LZA 3 (On LZA 2 plasmid) 
5’ – GCAGGCGGAGGAGAAAGCTAAACATTGCCAACAATAATTATAAGATTCTGC – 3’ 
3’ – GCAGAATCTTATAATTATTGTTGGCAATGTTTAGCTTTCTCCTCCGCCTGC – 5’ 
 
APOL1 LZA 4 
5’ – TTCTTGGTCCGCCTGCGCAATCTTATAATTATTGTTGAGAATGTTTAGC – 3’ 
3’ – GCTAAACATTCTCAACAATAATTATAAGATTGCGCAGGCGGACCAAGAA – 5’ 
 
APOL1 LZA 5 (On LZA 4 plasmid) 
5’ – CGCAATCTTATAATTATTGCCGGCAATGTTTAGCTTCTCCTCCAGCTCC – 3’ 
3’ – GGAGCTGGAGGAGAAGCTAAACATTGCCGGCAATAATTATAAGATTGCG – 5’ 
 
APOL1 LZA 6 (On LZA 5 plasmid) 
5’ – GTTTAGCTTCTCCTCCGCCTCCTGAGCCACCTTC – 3’ 
3’ – GAAGGTGGCTCAGGAGGCGGAGGAGAAGCTAAAC – 5’ 
 
 
APOL1 protein purification 
(For a detailed methodology see appendix 1) 
 
The pNIC28 plasmid containing the His-tagged APOL1 gene is transformed into Bl21-
DE3-RIPL cells, and grown for 16-18 hours in Overnight Express Media. The bacteria are then 
pelleted, and the inclusion bodes isolated. After solubilizing the inclusion bodes in the presence 
of Zwittergent 3-14, the APOL1 protein is subject to His-Affinity Purification and Size 
Exclusion Chromatography. The fractions are then run on an SDS-PAGE gel and coomassie 






Purification of MPB Labeled Proteins 
 
 Approximately 500 uL of rAPOL1 protein (11.6 uM) is incubated with 1 mM MPB for 
one hour at room temperature. After incubation, proteins are added to a 2 mL Centrifuge Column 
(Pierce, 89896) packed with 1 mL of monomeric avidin bond to sepharose beads (Pierce, 20228). 
The flow through is discarded, and the bound MPB labeled APOL1 protein is eluted with buffer 
containing 1 mM biotin. The excess biotin is removed by repeated rounds of washing in a Ultra-
15 Centrifugal Filter Unit with a 10,000 Dalton molecular weight cut-off (Amicon, UFC901024). 
The resulting protein solution is then concentrated down to ~500 uL, aliquoted and flash frozen 
in liquid nitrogen for storage at -80*C. 
 
24-hour trypanolytic killing assay 
 
Lister-427 derived T. b brucei 427 were grown and cultured in HMI-9 medium. The 
human serum sensitive cell line was then exposed to rAPOL1 dilutions of the various mutants 
purified (indicated for each graph). The assay was performed in a 96-well plate, in which 5 x 
10^5 cells/mL were combined with the rAPOL1 (done in triplicate) and allowed to incubate for 
20 hours at 37*C (5% C02). The viability of each well was assessed using the alamarBlue assay 
as described by the manufacturer (Invitrogen, DAL1100). Data was analyzed and graphed using 
Prism 7 software by GraphPad. 
 
Planar lipid bilayer experiments 
 
Both the polar lipids from asolectin (lecithin type IIS from Sigma) and cholesterol 
(sigma, C8667) were dissolved together in pentane at concentrations of 1.5% and 0.5% (wt/vol), 
respectively. At room temperature, a Teflon partition with a ~100 um hole, separating two 
chambers of 1 mL total volume each, was coated with 3% (vol/vol) squalene (Sigma, S3626) in 
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petroleum ether. The solvent was then allowed to evaporate, and buffer was added to both the cis 
and trans chambers via syringes. The solutions were next layered with 20 uL of the 
asolectin/cholesterol solution, and the trans chamber solution was raised above the hole, 
immediately followed by the cis chamber. At this time, we expected a change in the capacitance 
roughly equivalent to 100 pF. If not observed, the solutions levels were brought below the hole, 
and then raised again. This process was repeated until a stable bilayer was formed as evidenced 
by the measured capacitance.   
 Salt bridges made of 3% (wt/vol) agar and 3 M KCl connected the Ag/AgCl electrodes to 
the solutions in the cis and trans compartments. The starting buffer solution contained 5 mM 
Potassium Succinate, 5 mM HEPES, 150 mM KCl, 5 mM CaCl2 and 0.5 mM EDTA, pH 7.2 
unless otherwise stated. Each chamber had a lower depression to allow for stirring by magnetic 
fleas so the pH could be titrated by addition of HCl or KOH. Voltage of the system was 
maintained by the BC-535C bilayer clamp (Warner Instruments), and the current output was 
passed through a low-pass eight pole Bessel filter (Warner Instruments) at 10 Hz. For this setup, 
voltage is applied relative to the cis chamber. Recording of the current response was done with 
IGOR NIDAQ Tools MX 1.0 and IGOR software (WaveMetrics) using the National Instruments 
analog to digital converter (NI USB-6211).  
 The selectivity of various APOL1 channels was done by measuring the reversal potential 
of macroscopic conductance with varying cis:trans activity gradients. Addition of 50 uL of 3 M 
KCl to the cis solution created an ion gradient, and the voltage required to zero the current 
(reversal potential) was acquired. The measurement of the reversal potential at numerous ion 
concentration gradients was compared to ideal cation and anion selectivity’s as determined by 
the Nernst Potential: 
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Erev = -59 mV x log10 [αK+cis/ αK+trans]  
 
Where αK+ is the relative activity of the potassium ion due to ionic interactions in the buffer 
solution, which is based on the Debye-Huckel limiting law. 
 
Dimerization assays 
 Recombinant APOL1 proteins were diluted into buffer containing 5 mM Succinate, 5 
mM HEPES, 150 mM KCl, 5 mM CaCl2 and 0.5 mM EDTA, pH 7.2 (same as bilayer 
experiments). The buffer obviously lacked reducing agents such as DTT or B-mercaptoethanol 
because we wanted to promote the formation of disulfide bonds. We could use 1 M HCl or KOH 
to titrate the solutions between pH 5.6 and pH 7.2, respectively. Approximately 232 nM 
concentrations of the APOL1 proteins were incubated at room temperature for a total of two 
hours. The varying conditions included: two hours at pH 7.2, one hour at pH 5.6 and one hour at 
pH 7.2, and two hours at pH 5.6 followed by a brief neutralization. 30 uL of sample were then 
added to 35 uL 2x Laemmli Sample Buffer (Bio-Rad, 1610737), and a total of 25 uL of sample 
(~25 ng protein) was run on an AnyKD Tris-Glycine gel (Bio-Rad, 4569033) at 110 V for ~1.5 
hours. The gels were then silver stained in accordance with the manufacturer’s instructions 
(Pierce, 24612). In experiments testing the effects of SRA on disulfide formation, a two-fold 





Chapter 1: Identifying the Selectivity filter and Pore Lining 






Humans have an innate immunity to some Trypanosoma species (sp.) because of a subset 
of high-density lipoproteins termed Trypanosome Lytic Factors[43]. Two integral components of 
this complex, Apoliporotein A-1 and Haptoglobin-related protein, form the structural scaffold 
and the ligand for receptor-mediated endocytosis, respectively [46, 47]. The lytic component of 
this complex, Apolipoprotein L1, is a pH-gated ion channel and the focus of this study [16]. 
 Uptake of TLF, and thus APOL1, into the parasite is necessary for Trypanolysis, and is 
facilitated by clathrin mediated endocystosis [114]. These clathrin-coated vesicles are then 
trafficked to the endosome, which is acidified by V-ATPases, with the help from Adapter 
Protein-2 complexes. [115, 116]. Now activated, the APOL1 causes colloid osmotic swelling and 
lysis due to equilibration of the ion electrochemical potential by cation flux across the plasma 
membrane [41], which could be explained by trafficking of APOL1 to the plasma membrane 
resulting in channels selective for cations at the cell surface. Indeed, recombinant APOL1 is able 
to lyse trypanosomes in vitro, as well as form pH-gated ion channels in planar lipid bilayers [16]. 
Within this system, APOL1 will only insert into phospholipid/cholesterol membranes at acidic 
pH, and opens upon subsequent neutralization, thus mimicking the conditions during vesicular 
recycling from the acidic endosome to the plasma membrane with subsequent exposure to the 
neutral environment of the extracellular milieu.  
Currently, the exact mechanism for ion channel formation by APOL1 is poorly 




domains [14]. Most notably, the first two predicted transmembrane domains form a Helix-Loop-
Helix (HLH) structure (residues 60-235), reminiscent of bacterial colicins and diphtheria toxins. 
A peptide fragment containing only the HLH helices (TM 8 and 9) of Dptx is able to insert into 
planar lipid bilayers at acidic pH and form pores with similar conductance to that of full-length 
diphtheria toxin [79]. A similar peptide of APOL1 (HLH helicies TM 1 and 2) was generated 
and tested in planar lipid bilayers (residues 60-235), however the properties of the observed 
conductance are vastly different than that of full-length rAPOL1 [15]. Despite this finding, the 
region (residues 60-235) has been extensively referred to as the pore forming domain of APOL1, 
although there is little evidence to support this claim other than the structural similarity.  
The C-terminal domain of APOL1 has been scarcely studied as a region involved in 
channel formation, although this is the site of interaction with Serum Resistance Associated 
Protein (SRA). Specific to the human infective parasite T. brucei rhodesiense, SRA binds to the 
C-terminus of APOL1 under acidic conditions and prevents trypanolysis both in vivo and in vitro 
[14, 61]. In planar lipid bilayers, pre-addition of SRA to the cis chamber prevents channel 
formation upon neutralization [16]. However, a stable acidic conductance was formed, 
suggesting APOL1 was still able to insert into the membrane but was unable to open at neutral 
pH. Furthermore, the same group noted deleting more than 10 of the final C-terminal amino 
acids resulted in loss of trypanolytic activity and channel forming properties. Despite all this, the 
precise involvement of the C-terminus in channel formation of APOL1 is still unknown.  
While the domains of APOL1 are yet to be confirmed, it is generally understood that the 
protein forms cation-selective channels in the open conformation. In planar lipid bilayers, after 




further manipulated by adding 3 M KCl to the cis chamber (Figure 6A). Under conditions of 
cis/trans pH 7.2, rAPOL1 was found to be ideally selective for both potassium and sodium over 
chloride ions [16]. Additionally, a second group inserted rAPOL1 into unilamellar lipid vesicles, 
and measured chloride efflux from the liposomes when paired with various ionophores(Figure 
6B). When rAPOL1 was first inserted into the lipid vesicles at acidic pH and subsequently paired 
with the chloride ionophore CI1 at neutral pH 8.0, there was chloride efflux from the liposomes, 
indicating rAPOL1 was able to generate a cation-selective counter-current [65]. However, the 
group noted chloride efflux at extracellular pH 5.0 when rAPOL1 was paired with the potassium 
ionophore valinomycin, signifying APOL1 was permeable to chloride ions.  Although the 
authors noticed the similarity to bacterial colicins, which also confer pH- switchable ion 
selectivity, they did perform amino acid substitutions to identify the residue(s) involved [117]. In 
contrast to this result, the selectivity of APOL1 from purified TLF was tested in the low 
conductance (acidic pH) state in planar lipid bilayers, and the protein was found to be primarily 
permissive to cations [55]. With the conflicting results in the low conductance state, it is unclear 





Utilizing the secondary structure prediction software Jpred 4, we identified four putative 
transmembrane domains (TM) within APOL1. The first two form a putative HLH, similar to 
bacterial colicins and diphtheria toxin, whereas the latter two transmembranes (TM 3 and TM 4) 
are independent of one another (Figure 7). We hypothesized at least one of the predicted 
transmembranes could be the pore lining region or the selectivity filter of APOL1. But without 




To better characterize the selectivity of APOL1, we wanted to test the effect of pH on the 
channel’s preference for cations. We first tested the selectivity in planar lipid bilayers at pH 7.2 
cis/pH 7.2 trans, and confirmed the previously published result that APOL1 is an ideally 
selective cation channel. However, APOL1 appeared to lose cation selectivity as the cis chamber 
was changed to pH 5.6, and was further reduced when dropped to pH 5.4 (Figure 8). This 
property is reminiscent of bacterial colicins, which loses their cation selectivity as the cis pH is 
dropped [118]. However, unlike the bacterial colicin, APOL1 has three glutamate residues in its 
HLH, and maintained its ideal cation selectivity under the reverse conditions of cis pH 7.2/trans 
pH 5.6 (Figure 8). Considering this result, we wanted to test if the amino acids in the putative 
HLH, specifically the three glutamate (E) residues reminiscent of diphtheria toxin, had an effect 
on channel selectivity.  
 
 
Because of unpublished work by Russell Thomson, we know the baboon variant of 
APOL1 is not ideally cation selective at pH 7.2 cis/pH 7.2 trans (data not shown). Because the 
baboon shares only one of the glutamate residues in the HLH with human APOL1, we reasoned 
that one or both of the other two could contribute to APOL1 pH-regulated cation selectivity. 
However, amino acid changes of glutamate-201 to alanine (E201A) and/or glutamate-213 to 
glycine (E213G) in the human APOL1 to mimic the baboon residues, resulted in a protein that 
remained ideally cation selective at cis pH 7.2 (Figure 9). Furthermore, the substitutions had no 
effect on APOL1 lytic activity in an in vitro Trypanolytic killing assay (data not shown). 





Seeing as Thomson and Finkelstein documented the importance of the C-terminus in 
APOL1 function, we focused on the final predicted transmembrane sequence of APOL1 to try 
and elucidate the channel selectivity filter. This region spans amino acids 335-356, and 
noticeably includes two aspartate residues at positions 337 and 348, and one glutamate residue at 
position 355 (Figure 7). Hypothesizing either of these residues could contribute to channel cation 
selectivity because they become de-protonated at neutral pH, we individually substituted an 
asparagine in place of the aspartate. Accordingly, overall R-group structure was maintained, 
although the side chain is now polar-uncharged. The APOL1 proteins, aspartate-337 to 
asparagine (D337N) and aspartate-348 to asparagine, were then subjected to in vitro trypanolytic 
assays to test lytic capacity (Figure 9). APOL1 D337N retained lytic activity with an LD50 ≈ 100 
ng/mL, nearly identical to that of the G0 APOL1 (Figure 9). In addition, the there was no effect 
of the D337N substitution on channel formation or pH gating in the planar lipid bilayer system 
(Figure 12). Conversely, D348N was unable to lyse T. b. brucei 427 at concentrations nearly 
eight-fold higher than the LD50 of approximately ~100 ng/mL for G0 APOL1 (Figure 10). This 
was consistent with a severely diminished acid-to-neutral macroscopic conductance increase of 
D348N, only 2-3 fold, when compared directly to G0 APOL1 (200-500 fold) during the same 
planar lipid bilayer experiment (Figure 13). 
We then investigated the effect of the D337 and D348 substitutions on ion selectivity of 
the human APOL1 channel. Whereas APOL1 D337N remained ideally cation-selective at pH 7.2 
cis/pH 7.2 trans, the D348N substitution resulted in a shift towards anion selectivity (Figure 11). 
If cation selectivity was due to the de-protonation of aspartate at neutral pH, then the selectivity 
of APOL1 at acidic pH should be comparable to that of D348N APOL1 at neutral pH. Indeed, 




D348N at neutral pH (Figure 8), suggesting that titration of D348 is responsible for pH-
dependent selectivity of G0 APOL1.  
To confirm the contribution of this residue to selectivity, we replaced aspartate-348 with 
a histidine (H), an amino acid side chain that becomes positively charged below pH 6.1. Like 
APOL1 D348N, the D348H substitution resulted in a protein unable to lyse African 
trypanosomes in vitro (Figure 10). Additionally, the D348H substitution resulted in a channel 
that minimally responds to pH, with only a ~2 fold increase in macroscopic conductance upon 
neutralization, reminiscent of the effect seen with the D348N substitution (Figure 14A). 
Remarkably however, the histidine substitution resulted in almost complete loss of ion selectivity 
in planar lipid bilayers at neutral pH, whereas at acidic pH 6.1, the macroscopic conductance 
became strongly anion-selective (Figure 14B). This result suggests that protonation of the 
substituted histidine at pH 6.1 governs the shift toward anion selectivity. Taken together, these 
data strongly suggest that protonation of the aspartic acid at position 348 governs APOL1 
selectivity. 
Discussion: 
 While it is well understood that APOL1 is a pH-gated cation channel, the domains 
responsible have yet to be categorized. More specifically, the pore-lining region and selectivity 
filter have yet to be identified. With previous established work showing that recombinant 
APOL1 can form conductances in planar lipid bilayers, we began to test the effects of amino acid 
substitutions in this system. Although the putative HLH has been heavily implicated throughout 
the literature, we found that amino acid substitutions within this region had no effect on APOL1 
ion selectivity. With a paper by Thomson and Finkelstein highlighting the importance of the C-




Interestingly, the substitution of D348N resulted in diminished macroscopic channel 
conductance and a loss of cation selectivity, indicating that the pore- lining region is constituted, 
at least in part, by the fourth predicted transmembrane domain (residues 335-356). Furthermore, 
replacing the aspartic acid at this position with a histidine resulted in an APOL1 channel that was 
anion selective at acidic pH. Taken together, these data challenge and significantly add to the 
current understanding of APOL1 structure and domains.  
Based on previous findings and potential similarities to diphtheria toxin and bacterial 
colicins, our lab extensively explored the predicted HLH of APOL1 as the potential pore-lining 
region. However, we found no evidence that the HLH itself lines the ion channel, as the 
E201A/E213G substitutions had no effect on channel selectivity (Figure 9). This is in contrast to 
the pore-forming DpTx, wherein substitution of charged HLH residues affected either single 
channel conductance, or both selectivity and conductance [84, 85]. Moreover, a minimal peptide 
fragment containing just the HLH of diphtheria toxin or colicin was sufficient to form channels 
in planar lipid bilayers with similar properties to the full-length peptide [79, 89]. While a similar 
fragment of APOL1 (residues 60-235) was shown to form chloride selective channels, it lacked 
the ideal cation selectivity we have described here, and is therefore difficult to compare to our 
findings [15]. 
Also in contrast to the bacterial pore-forming toxins, APOL1 contains some 170 amino 
acids C-terminal of the HLH. Truncation at the C-terminus of 10 or more amino acids abolished 
trypanolytic activity and is associated with loss of channel-forming ability [16, 71, 119]. 
Focusing on the C-terminal putative transmembrane domain as a prospective channel-lining 
region (residues 335-356), we identified two charged aspartates (residues 337 and 348) and a 




Substitution of aspartate to asparagine (D337N) within the putative transmembrane region had 
no effect on either the pH-dependent conductance properties or charge selectivity (Figure 11 and 
12). The D337N substitution happens to be a naturally occurring variant within the human 
population, and we did not find any functional differences concerning channel properties [120]. 
Conversely, the glutamate-355 was found to play a small role in pH gating of human APOL1 
(Russell Thomson, unpublished). Substitution with glutamine residue resulted ~1 pH unit shift in 
channel opening towards a more basic environment, while substitution with glycine had the 
opposite effect (~1 pH unit towards acidic). Based on this evidence it stands to reason that 
glutamate-355 may be a pH sensor, or more likely affects the microenvironment of the actual pH 
sensor. 
Whereas the glutamate-355 had a small effect on channel gating, aspartate-348 appears to 
be crucially important to the pH-dependent conductance of cations through the channel. The 
D348N substitution in particular was associated with reduced overall ion conductance compared 
to G0 APOL1, and decreased cation selectivity at neutral pH similar to G0 APOL1 at pH 5.4 
(Figure 11 and 13). Substitution for histidine (D348H) reduced cation selectivity still further at 
neutral pH, and actually reversed selectivity to anions at acidic pH 6.1 (Figure 14). We were 
unable to drop the pH further, as thechannels became largely unstable at pH < 6.0. But with 
histidine having an R-group pKa = 6.0, it stands to reason that a further decrease may have led to 
an ideally anion selective channel. Interestingly, there is a similar effect observed with the 
TASK-1 family of two-pore potassium channels, in which mutations that caused loss of 
selectivity also reduced channel conductance upon pH gating [121]. Notwithstanding, we find no 
evidence at this time that APOL1 has any structural or domain similarities to this family of 




Thomson had no channel gating response upon neutralization, heavily implicating these two 
residues as the main pH sensors (Fig 10). But regarding charge selectivity (cations versus anions) 
of APOL1, it appears to be electrostatic in nature, and is dependent to a large extent on the 
protonation status of a single residue, aspartate-348.   
Having now identified the selectivity filter, we will try to set the record straight regarding 
APOL1 selectivity. Our findings agree with previously published reports that APOL1 is cation 
selective at neutral pH in both planar lipid bilayers and lipid vesicles [16, 65]. However, there is 
conflicting data on the selectivity of APOL1 at acidic pH. Utilizing TLF purified from humans, 
Portela et al. found APOL1 to be non-ideally cation selective in planar lipid bilayers, with a 
pK/pCl of ~4.65 at cis pH 5.5/trans pH 7.4 [55]. Compared to our results, this falls between our 
estimates of pK/pCl ~5.1 at cis pH 5.6 and ~2.88 at cis pH 5.4, in agreement with our assessment 
that APOL1 becomes increasingly anion selective as the aspartate-348 is protonated/neutralized. 
But when full-length recombinant APOL1 was inserted into phospholipid liposomes at pH 5.0, 
anion conductance was observed when paired with the cation carrier valinomycin, suggesting 
APOL1 was selecting chloride over potassium in the system [65]. However, the anion selective 
conductance at pH 5.0 was rather large compared to what we find here, and it is feasible this is 
the result of a different species altogether. Additionally, they did observe a small potassium 
efflux when paired with the chloride carrier Cl1 at extracellular pH 5.0, indicating APOL1 most 
likely allows the efflux of both potassium and chloride in the inserted/closed state, as we have  
found here. This further supports the idea that protonation/de-protonation of aspartate-348 
controls ion selectivity of APOL1. 
The findings in this section also shed light on the mechanism of trypanolysis by APOL1. 




cytoplasmic swelling when trypanosomes are treated with human serum [41]. This effect can be 
delayed by adding sucrose to the growth media to prevent osmotic swelling, or if NaCl is 
partially replaced with the larger ions tetramethylammonium+ (for Na+) or gluconate- (for Cl-), 
thus preventing ion flow across the membrane [55], therein supporting the hypothesis that 
APOL1 forms cell surface channels after insertion into the endosome membrane. Other groups 
have suggested APOL1 forms pores in the lysosomal membrane, causing lysosomal swelling and 
eventual parasite death [13, 15, 54]. A recent paper observed that lysis results from both 
lysosomal and mitochondrial membrane disruption, the latter of which is due to the formation of 
APOL1 megapores in the outer mitochondrial membrane [60]. In regards to the lysosome 
hypothesis, the residues responsible for pH gating would never “see” pH 7.2 after acidification in 
the lysosome, so the channels would presumably remain in the closed state with minimal 
conductance. Considering the loss-of function D348N and D348H substitutions result in 
decreased open state conductance at neutral pH, but appear to have no effect on insertion or the 
closed channel conductance at acidic pH (Figure 13 and 14), it appears that trypanolysis is 
dependent on the open state of the APOL1 channel. The formation of APOL1 megapores in the 
mitochondrial membrane also seems unlikely, as we have never observed anything other than the 
highly ion-selective, pH-gated properties of APOL1 described herein. Although APOL1 could 
possibly collaborate with other trypanosome proteins to form a megapore, it would remain to be 
explained how the loss of function D348N and D348H substitutions might affect this process 
(Figure 10). Rather, we show the APOL1 D348N and D348H substitutions dramatically reduce 
APOL1 cation channel conductance while eliminating trypanosome killing. Therefore, the data 
further backs the notion that endocytic recycling of APOL1 drives colloid osmotic lysis of the 





With a firm understanding of the selectivity of the APOL1 channel, we wanted to 
speculate on the pore size. Both unpublished by Russell Thomson and published data indicate 
APOL1 is a non-selective cation channel, meaning it allows the passage of multiple cations (Na+, 
K+, Ca2+) [16]. The selectivity experiments presented here are performed exclusively with 
potassium, the largest of the three ions permissible to APOL1, which has a crystal radius of ~3 Â 
[122]. The family of voltage-gated potassium channels (VGKC) have a pore diameter of ~5 Â, 
which permit the diffusion of dehydrated potassium ions through the channel [100, 123]. 
However, potassium channels are highly selective for potassium over other cations, whereas 
APOL1 permits the flux of both Na+ and Ca2+ in addition to potassium. Therefore the pore 
diameter of APOL1 is likely different than that of the VGKCs. Still, it can be expected the 
APOL1 pore cannot be smaller than that of the VGKC channel considering it generates a 
potassium dependent conductance in planar lipid bilayers [16]. To determine an upper estimate 
of pore diameter, we turned to the colicin family of bacterial toxins, of which APOL1 shares a 
putative helix-loop-helix motif. Colicin A and B both permit diffusion of sodium and potassium 
[124]. However, they also permit the larger monovalent ions rubidium, cesium and 
tetraethylammonium to pass through the pore. It is interesting to note that replacing sodium in 
the media with tetraethylammonium delays APOL1 mediated trypanolysis, thus we can infer the 
molecule is unable to pass through the APOL1 channel [55]. Considering colicin E1, which is 
predicted to be similar to colicin B, was experimentally determined to have a minimum pore 
diameter of ~8 angstroms, which we would expect to be the upper limit for the APOL1 pore 
diameter [117]. Furthermore, the class of non-selective cation channels (NSCCs), specifically the 
nicotinic acetylcholine receptor, could also be a suitable gauge of APOL1 pore diameter. The 
functional channel allows permeation of Na+, K+ and Ca2+, and utilizes two rings of negatively 
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charged amino acids to confer cation selectivity by repulsion of anions [125]. These channels 
have an estimated pore radius of ~6.5 Â, and due to the similarities in selectivity and amino acid 
composition be fairly analogous to APOL1 channels [93]. Taken together, we predict the 
minimum pore radius of the APOL1 channel to be ~6.5 Â, with a lower limit of 5 Â and an upper 











The APOL1 protein gives humans resistance to the animal infective parasite T. brucei 
brucei due to its ability to form ion channels in the parasite plasma membrane [16]. However, 
humans are still infected by the subspecies T. brucei rhodesiense due to the expression of a 
single protein, serum resistance-associated protein (SRA) [13, 70]. Surface plasmon resonance 
experiments of C-terminal peptide fragments (residues 365-398) show SRA binds to this region 
with nano-molar affinity under acidic conditions, which is likely mediated by an electrostatic 
interaction rather than hydrophobic [13, 14, 73]. When pre-added to planar lipid bilayer 
experiments, recombinant SRA did not appear to have an effect on APOL1 insertion at acidic 
pH. However, it does prevent APOL1 channel formation upon neutralization, thus hinting at the 
importance of the C-terminus for channel formation [16]. Additionally, the same group reported 
truncations of APOL1 (del: 349-398) prevented APOL1 membrane insertion and channel 
opening. 
Secondary structure prediction software Jpred 4 identifies a putative heptad repeat in the 
C-terminus of APOL1 (Figure 18). The protein-folding motif often forms a superhelical structure 
consisting of two or more alpha helices, and is stabilized by both van der waals and electrostatic 
forces (Figure 17) [126]. Based on the occurrence of this structural motif, it is reasonable to 
assume the APOL1 channel is an oligomer. In support of this theory, replacement of amino acids 
residing in the hydrophobic core resulted in either partial (alanine) or complete (serine) loss of 
Trypanolytic activity in vitro [71]. Furthermore, a recent computational approach determined 




APOL1 oligomerization has also been implicated in kidney disease of those with recent African 
Ancestry [77]. The renal risk variants, G1 (S342G/I384M) and G2 (del: 388/389), were found to 
form numerous higher order oligomers in the mitochondria, unlike the ancestral G0 we have 
focused on here [113]. Interestingly, both variants have missense mutations in the C-terminus 
that could be adding to the stability of the coiled-coil. Despite these findings, the exact role the 
C-terminus plays in APOL1 ion channel activity and kidney disease is poorly understood. We 
therefore want to determine the role of the C-terminal heptad repeat on channel formation, and 
whether it is dependent on oligomerization by the putative coiled-coil. 
 
Results: 
We sought to identify the importance of the C-terminal domain on APOL1 channel 
formation. Past studies have noted a potential leucine zipper motif in this region, as well as 
observing C-terminal truncations causing a loss of trypanolytic and channel activity [16, 71]. The 
heptad repeat within this region is defined by a leucine residue being positioned every 7th amino 
acid, thus falling into the same “d” position in an alpha helix (Figure 18B). Furthermore, a 
hydrophobic residue is located on the same helical face, and in this case occupies the “a” 
position (Figure 18B). This strip of “knobs” (leucines) and “holes” (hydrophobic residues) can 
form either dimers or oligomers, which are stabilized by van der waals forces (Figure 17). 
Additionally, charged residues in the “g” and “e” positions can potentially form salt bridges, 
further stabilizing the coiled-coil interaction (Fig 13). 
In order to begin testing the importance of the C-terminal heptad repeat, we made 
numerous site directed amino acid substitutions in this region and purified the recombinant 




the smaller, but still hydrophobic, alanine amino acid resulted in a protein that was no longer 
able to lyse T. brucei 427 in vitro (Fig 14A and B). In contrast, a substitution of a cysteine (C) 
residue into either the “a” position alanine-375 (A375) to cysteine or “f” position lysine-373 
(K373) to cysteine had no effect on rAPOL1 trypanolytic activity (Figure 19A and B). 
Furthermore, an alanine substitution with cysteine (A363C) N-terminal of the putative coiled-
coil still retained lytic activity, albeit slightly less compared to G0 rAPOL1. The final rAPOL1 
protein, which combines the LZA and A375C substitutions (LZA A375C), was unsurprisingly 
non-trypanolytic (Figure 19A and B). 
We next sought to characterize the LZA rAPOL1 channel formation in planar lipid 
bilayers to uncover the loss of activity in trypanolytic assays. The LZA protein is added to the cis 
chamber with a cis pH 7.4/trans pH 7.4, and no change in the current is observed as expected 
(Figure 20A). When the cis chamber is acidified with 1 M HCl to pH 5.4, which typically allows 
rAPOL1 to insert into the bilayer, we detect a slight increase in the macroscopic conductance. 
However, neutralization of the cis chamber to pH 7.4 to open the channels results in slight 
membrane instability, followed by stabilization of the current without any fold increases in ion 
movement through the channel (Figure 20A). To confirm this result, we tested the LZA protein 
against the G0 rAPOL1 on the same bilayer membrane. After repeating the same procedure as 
above, we noticed the same result for the LZA protein; insertion at acidic pH, but no fold 
increase of conductance upon neutralization (Figure 20B). An equivalent amount of G0 rAPOL1 
was then added to the trans chamber, which was then acidified to allow for membrane insertion. 
After waiting approximately the same amount of time, about ~30 seconds, the trans side was 
neutralized (Figure 20B). Indeed, we see a large increase in the conductance of the system, 




Seeing that substitution of the four leucines for alanines in the C-terminal heptad repeat 
resulted in complete loss of trypanolytic activity and channel opening, we investigated the 
importance of these residues further. Our goal was to generate sequential LZA rAPOL1 proteins 
and discern partial loss of activity in 24-hour trypanolytic assays (Figure 21A), thus implicating 
the entirety of the heptad repeat as crucial to APOL1 channel function, rather than a single 
substitution causing the loss of function effect we observed with LZA rAPOL1. Substitutions 
were inserted via PCR mutagenesis, and the proteins were isolated and purified from E. coli.  
Interestingly, the LZA 1 protein had a significant loss of activity, with the LZA 2 and 3 rAPOL1 
proteins having complete loss of lytic activity at concentrations up to 800 ng/mL. (Figure 21B). 
Conversely, the LZA 4 had activity nearly identical to that of G0 rAPOL1, suggesting the C-
terminal leucines have less of an impact on lytic activity than the N-terminal residues (Fig 16B). 
This was further supported by the LZA 5 and 6 proteins, which still retained some activity, albeit 
marginal in the case of LZA 6. (Figure 21B) However, it is unclear if these substitutions either 
prevent insertion or diminish channel conductance. But based on the earlier experiments 
highlighting LZA rAPOL1 can still insert upon acidification into the bilayer system, we can 
deduce it is the latter (Figure 20A).  
Having extensively examined all of the “d” position leucines in the heptad repeat, we 
sought to test the tolerance of cysteine substitutions on different faces of the putative alpha helix. 
The first substitution was targeted to position 375, and replaced an alanine predicted to occupy 
the “a” position of the coiled-coil (Figure 19A). A second substitution of K373C, would insert a 
cysteine on the opposite face of the helix in the “f” position (Figure 19A), and should have no 
effect on the putative hydrophobic face. If both substitutions are tolerated such that they retain 




inhibit either of these characteristics. Indeed, both K373C and A375C were well tolerated in 
trypanolysis assays (Figure 19B), and formed significant conductances in planar lipid bilayers 
after insertion and subsequent neutralization (Figure 22A and 23A). Therefore, we can conclude 
A375C and K373C are fully functional proteins.  
With both the A375C and K373C proteins having both trypanolytic and ion channel 
activity, the next step was to test if incubation with the small, charged molecule MTSET would 
inhibit or disrupt these functions. We hypothesize that the addition of the charged moiety to the 
hydrophobic pocket of the coiled-coil would disrupt channel formation (“a” position; 375), 
whereas a small molecule attached to the hydrophilic face (“f” position; 373) would have no 
effect. To begin testing this, the A375C APOL1 was added to both sides of the bilayer chamber, 
with a large molar excess of MTSET added only to the cis side (Figure 22B). After a 10-minute 
incubation at pH 7.2, the cis chamber was acidified with 1 M HCl. A ~1pA increase in 
conductance was observed afer ~30 seconds, suggestive of APOL1 insertion into the bilayer. 
However, upon neutralization there was membrane instability, followed by no large increase in 
conductance. Intriguingly, this effect mirrored what we observed for the LZA channel formation 
characteristics (Fig 15A). The trans chamber was then acidified to allow for insertion of the un-
treated A375C, and neutralization resulted in a large conductance change confirming the A375C 
protein can form functional channels and the membrane was intact (Figure 22B).  
With pre-incubation of MTSET ablating channel opening of APOL1, we wanted to test 
the effect on already formed channels.  The A375C protein was thus added to a previously 
acidified cis chamber, given satisfactory time to insert into the bilayer, and then neutralized 




concentration of 1 mM. Over time the macroscopic conductance began to slowly decrease, 
suggesting the MTSET was inhibiting the channels. To confirm this effect was specific to the cis 
side, we added 1 mM MTSET to the trans chamber, and there was no observable increase in 
conductance loss over time (Figure 22C). Therefore it appears the MTSET effect is cis specific, 
and potentially due to disruption of the hydrophobic face of the coiled-coil. 
To test if the effect of MTSET seen with the A375C protein was a specific interference 
event due to targeted labeling of the cysteine residue or a non-specific interaction, we generated 
the K373C mutant. The substitution of cysteine was predicted to replace the lysine in the “f” 
position of the helix, and therefore have no effect on the hydrophobic pocket (Figure 17B). 
Unsurprisingly, the protein retained normal lytic function in a 24-hour killing assay, and was 
able to form pH-gated channels in the planar lipid bilayer (Figure 19B and 23A). When the 
protein was pre-incubated with a large molar excess of MTSET before channel formation, 
K373C was able to insert into the bilayer and displayed a conductance increase in response to cis 
pH neutralization nearly identical to that of the untreated K373C (Figure 23A and B). 
Additionally, the channels still reacted to titrations in the cis solution pH, implying they are 
completely functional. We can therefore conclude the MTSET effect in specific to the A375C 
protein, due to its positioning in the hydrophobic hairpin of a coiled-coil structure. 
With mounting evidence to support APOL1 is indeed an oligomer as a functional 
channel, we wanted to test this concept further. We hypothesized combining the G0 rAPOL1 
with a non-functional variant in a 24-hour trypanoltyic assay could rescue killing. If the protein 
does indeed form oligomers, having a large fold difference in non-functional to functional 
protein could cause a reduction in expected lytic activity. On the other hand, increased lytic 




APOL1 must be an oligomer as a functional channel. As the non-functional protein we chose 
both the D348H and LZA proteins. The former still showed an ability to insert and generate a 
small conductance in the bilayer at neutral pH, while the latter could not theoretically dimerize 
and therefore interact with the G0 protein (Figure 14A and 20A). Oddly, however, an 8-or 16-
fold ratio of non-functional to functional APOL1 had no effect on the lytic potential of G0 
APOL1 in a 24 hour assay regardless of which variant was used (Figure 24).  
In order to observe oligomers of APOL1 biochemically we again turned to the A375C 
protein. Utilizing the notion that disulfides form under neutral, non-reducing conditions, we 
incubated the protein under different buffer pH values for 2 hours to see if dimers formed more 
readily. As a control the A363C (lytic) and LZA A375C (non-lytic) proteins were first tested in 
trypanolyic assays and then for ability to form disulfides under the same conditions. Keeping the 
A375C protein at neutral for two hours showed no signs of disulfide formation, suggesting the 
two cysteines are not located near one another under these conditions (Figure 25A). However, 
acidifying for an hour followed by neutral conditions for one hour  (to promote disulfide 
linkages) showed a dimer band of APOL1 on a non-reducing SDS gel that was silver stained to 
visualize proteins. Keeping the protein at acidic for 2 hours and only briefly neutralizing had no 
indication of disulfide formation, potentially because sufficient time was not given for the 
disulfide to form spontaneously (Figure 25A). Conversely, both the A363C an LZA A375C 
proteins showed a slight disulfide band in all three conditions, suggesting the dimers are non 
specific to the pH changes of the buffer (Figure 25A and D). Therefore, it stands to reason 
acidification drives stabilization and potential oligomerization of the C-terminal heptad repeat, 
and thus enables the cysteines within the coiled-coil to get close enough that the disulfides are 




Previous work has shown that SRA binds to the C-terminus of APOL1, and is able to 
prevent channel opening upon neutralization. It is then possible that this effect is due to SRA 
blocking the C-terminal domain from forming a coiled-coil, and thus destabilizing the channel 
and saving the parasite from APOL1-mediated lysis. To test this theory, we incubated the A375C 
protein under the same conditions as before, but in the presence of a 2-fold molar excess of 
rSRA. As expected, there were no dimer bands in either the 2-hour neutral or 2-hour acidic lanes 
(Figure 25B). However, we did observe two dimer bands of ~90 kD (APOL1/APOL1) and 
~70kD (APOL1/SRA) in the 1-hour acidic plus 1-hour neutral lane (Figure 25B). Using Jmol 
pixel density analysis we concluded that the relative band intensity of the APOL1 homodimer 
without SRA to be ~12% (Figure 25C), whereas in the presence of SRA, the ~90 kD band 
approximated to be the homodimer was only ~2%, and the APOL1-SRA heterodimer was ~5% 
(Figure 25C). Thus, SRA appears to block the formation of the artificial disulfide in the A375C 
protein. 
Discussion: 
Here, we have extensively explored the C-terminal heptad repeat to test its role in 
APOL1 channel formation. Substitution of the leucines occupying the “d” position to alanine 
resulted in a protein unable to lyse T. b. brucei in vitro and incapable of forming large 
conductances in planar lipid bilayers despite unaltered membrane insertion. Sequential 
substitutions of the leucines caused partial loss of trypanolytic activity, with the loss of upstream 
leucines having a greater loss of lytic activity than the downstream residues. Furthermore, 
disruption of the putative hydrophobic strip with the positively charged MTSET thiol-reactive 
group results in loss of channel opening with the functional A375C rAPOL1 protein. 




disulfide formation with the A375C protein, which has the cysteine located on the putative 
hydrophobic face of the coiled coil. Interestingly, this reaction can be hindered by the presence 
of SRA., while substitution of the four “d” position leucines also ablated disulfide formation 
under the same conditions. Altogether, the data presented here indicates the C-terminus is crucial 
for APOL1 channel opening, and suggestive that APOL1 forms oligomers via a coiled-coil 
interaction upon acidification.  
The importance of the C-terminus in APOL1 trypanolytic and channel activity has had 
conflicting reports in the literature. A study first reporting APOL1 as the trypanolytic factor of 
human serum reported that the terminal 343-398 residues were dispensable for activity [71]. 
Additionally, a group observing the channel-forming potential of APOL1 found an N-terminal 
fragment from 60-235 could form anion pores in planar lipid bilayers and possessed bactericidal 
activity [15]. However, recent literature studying the full-length protein points to APOL1 being a 
pH-gated, cation channel in both planar lipid bilayers and large unilamellar vesicles [16, 55, 65]. 
Thomson and Finkelstein also observed a C-terminal amino acid truncation eliminating residues 
349-398 resulted in an inability to insert into planar lipid bilayers or form channels. Considering 
a single leucine to alanine substitution, which maintains hydrophobicity of the residue, in the C-
terminus (LZA 1; L371A) caused a large decrease in trypanoytic, it further supports the 
importance of this region. Taken together, it suggests the cation channel observed and studied 
here is indeed dependent on the C-terminus, while the N-terminal fragment studied by other 
groups may be a different, unidentified species. 
Noting the importance of the C-terminus in regards to APOL1 channel function, we 




substitution with either alanine or serine for residues (378/382/385) caused loss of lytic activity, 
in agreement with our observation that the LZA rAPOL1 was unable to lyse T. b brucei 427 in 
vitro or form a stable conductance in the bilayer system [71]. Furthermore, the sequential amino 
acid substitutions revealed replacement of multiple leucines (LZA 2/3/6) was required for 
complete loss of trypanolytic activity after a 24-hour experiment, implying cooperation of the 
leucines within the channel is essential for activity rather than a single residue. Additionally, 
insertion of a charged residue within the putative hydrophobic pocket by reacting the functional 
A375C protein with MTSET caused loss of channel activity. Therefore, we can infer that both 
hydrophobicity and “d” position leucines are necessary for APOL1 channel and trypanolytic 
activity. This evidence strongly suggests the heptad repeat at the C-terminus of APOL1 indeed 
forms a coiled-coil, which is dependent on these two properties, as a functional channel [126]. 
Looking more carefully into the trypanoltyic activity of the sequential LZA proteins gives 
further insight into the APOL1 channel. Of all the sequential LZA proteins tested, we want to 
highlight that the LZA 4 (L392A) protein had identical lytic activity as G0 rAPOL1. This was 
unexpected; especially considering that the LZA 1 (L371A) had an IC50 nearly four-fold higher 
than that of G0 rAPOL1. Interestingly, the G2 rAPOL1 has the fourth lecuine out of position due 
to a two amino acid deletion (388/389), suggesting this residue is dispensable for lytic activity. 
This observation is confirmed in the literature, where the G2 rAPOL1 was able to form large 
conductances in the planar lipid bilayer and kill trypanosomes comparably to G0 APOL1 [16]. 
Additionally, another group testing truncated mutants of APOL1 found that nine amino acid 
deletions in the C-terminus, which removed the L392 residue, also retained lytic activity [71]. 
Taken together, the entirety of the heptad repeat motif does not appear to be compulsory for 




Considering the evidence presented here suggests that APOL1 forms a coiled-coil as a 
channel via the C-terminus, we want to speculate on the oligomeric state of APOL1. Naturally-
occurring proteins with heptad repeats are able to form mutli-unit coiled-coils ranging from 
dimers all the way to hexamers [126]. However, an earlier group demonstrated the identity of the 
“d” position could strongly predict the oligomeric state of a coiled-coil [127]. Utilizing the 
coiled-coil domain of the yeast transcription factor GCN4, the group revealed switching of the a-
d positions from isoleucine-leucine, to isoleucine-isoleucine and leucine-isoluecine exclusively 
formed dimers, trimers, and tetramers, respectively. In the case of APOL1, only leucines are 
observed in the “d” position of the heptad repeat, which is analogous to a specialized coiled-coil 
termed a leucine zipper [128]. While we would then predict this motif to form a dimer, this 
structure is classically observed with DNA-binding proteins [129]. However, it should be noted 
the human voltage gated proton channel also rely on a coiled-coil for dimerization and slower 
gating kinetics [130, 131]. Indeed, the C-terminal heptad repeat contains a leucine in each of the 
“d” positions for the human voltage gated proton channel. So while we cannot completely rule 
out a higher order oligomer, we propose APOL1 is a dimer as a functional channel. 
Regarding APOL1 channel formation, the exact order of events leading to ion 
conductance is unclear. To better understand the precise order of events leading to channel 
formation, we looked into the alpha pore-forming proteins, which bear resemblance to APOL1 
due to predicted highly alpha helical secondary structure. These pores can assemble in either the 
“concerted” or “non concerted” model. In the “concerted” model, the protein binds to the 
membrane and the pore fully oligomerizes prior to membrane insertion; the “non concerted” 
model is defined by membrane binding and insertion either prior to or simultaneously with 
oligoermerization [132]. Based on the results generated in our study, it appears APOL1 most 
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likely follows the “non concerted” model of formation. This concept is supported by the LZA 
rAPOL1 and A375C-MTSET bilayer experiments, in which we observed both species could 
insert into the membrane but not form open channels upon neutralization. We predict these 
proteins entered into the membrane as a monomer, suggesting pre-dimerization is not necessary 
for insertion. We can then conjecture acidification allows for concurrent insertion of the HLH 
(178-220) and dimerization of the C-terminus. At an acidic pH, protonation of the glutamates 
(E201/E209/E213) in the HLH would allow for membrane insertion, while simultaneous charge 
neutralization of the C-terminus (365-398; pI of ~4.4) promotes the colied-coil interaction [14]. 
The inability to form open channels upon neutralization could be owed to the monomer’s 
inability to respond to pH changes.  
We also want to comment on the mechanism by which SRA blocks APOL1-mediated 
lysis of T. brucei rhodesiense. A past study observed SRA interacts with the C-terminal peptide 
of APOL1 under acidic conditions, and a single amino acid substitution of N388K drastically 
reduced this interaction [14]. This suggests SRA binds to the C-terminus within the heptad 
repeat, the region where we predict APOL1 forms a dimer. Therefore, SRA may block 
oligomerization of APOL1, preventing large cation conductances and accordingly evade 
APOL1-mediated cell death. Our experiments measuring disulfide formation of A375C 
confirmed this theory, in that that the presence of SRA limited the disulfide formation in the 1-
hour acidic/1-hour neutral condition. Additionally, Thomson and Finkelstein performed planar 
lipid bilayer experiments with recombinant SRA and APOL1. Pre-incubation of the cis chamber 
with SRA prior to adding G0 rAPOL1 and acidifying had no effect on APOL1 membrane 
insertion. However, it did prevent channel opening after neutralization, and appeared to remove 
the protein from the membrane [16]. Taken together, the above evidence strongly implies that the 
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APOL1 channel is indeed an oligomer, and SRA blocks this activity by interacting with the 
heptad repeat to evade trypanolysis. 
APOL1 has also been linked to cytoxicity leading to kidney disease in individuals with 
recent African ancestry. Currently there are several mechanisms implicated, including activation 
of the inflammasome, channels at the plasma membrane leading to potassium efflux, and 
opening of the mitochondrial permeability transition pore [81, 113, 133]. We propose that 
regardless of the downstream effects, the formation of the dimer is the upstream initiator of cell 
death. Within the same experiment, overexpression of the LZA protein in HEK293 cells showed 
LDH release, an indicator of cell death, similar to that of cells that were not transfected. 
Conversely, G0 APOL1 caused nearly 40% cell death in this overexpression system (Figure 26). 
Hence, it stands to reason the heptad repeat in the C-terminus is involved in cell death. However, 
we cannot rule out trafficking of LZA rAPOL1 to the membrane may be hindered, especially 
considering the KCNQ1 cardiac potassium channel is dependent on a C-terminal leucine zipper 
for correct cellular processing [134]. While we cannot discern between a lack of channel 
formation, evidenced here, or disruption of an intracellular protein-protein interaction in this 
system, we can indeed conclude the leucine zipper is relevant to APOL1 kidney disease. 
All together, the work in this section is highly suggestive that APOL1 is indeed an 
oligomer as a functional, pH gated channel. While the data presented here supports APOL1 as a 
dimer, more biochemical evidence will be needed to confirm this finding. Still, it appears the 
dimer is required for trypanolytic activity of T. b brucei, and SRA is able to inhibit this coiled-
coil interaction. The dependency on the dimer for channel activity may also have implications 
for APOL1-mediated kidney disease, and further research into the topic is required. 
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Ion channels are integral membrane proteins that allow the passage of ions from one side 
of the membrane to the other. Channels typically follow a specific overall topology, with each 
subunit spanning the membrane anywhere from two to seven times in order to form a channel 
through the lipid bilayer [135]. An intramembrane loop often acts as the selectivity filter, and the 
residues lining this region vary to allow for ion specificity by both charge and size restrictions. 
For the APOL1 channel, a lot of work has gone into the mechanism of APOL1 channel 
formation, yet very little is known about the channel topology. The first paper simply labeled 
three of the regions as the pore-forming domain (PFD; 60-235), the membrane-addressing 
domain (MAD; 250-290) and the SRA-interacting domain, and this remains the nomenclature in 
the literature today [15].   
 Recently, groups have attempted to determine the membrane topology and number of 
transmembrane domains of APOL1. In 2014, a group using PROFSec secondary structure 
prediction software predicted APOL1 has three transmembrane domains as a functional channel 
[14]. A biochemical approach to determining membrane topology was done by measuring the 
absorbance of tryptophans after insertion of the PFD of APOL1 into a vesicle system [65]. The 
authors concluded that the two transmembranes of the HLH (177-228) are able to span the 
membrane under acidic conditions, but subsequent neutralization of the extracellular milleu 
resulted in amino acids in the N-terminal domain to insert into the vesicles, despite there being 
no evidence of hydrophobic or transmembrane domains.  
 Recently, an in silico approach was taken to determine APOL1 channel membrane 






numerous solved protein structures, including the Talin triple domain, yeast fatty acid synthase 
and the cytotoxin MakA from Vibrio Cholera. With this approach, they determined each subunit 
of APOL1 contributes five transmembrane domains to form the pore [81]. Here, we use the Jpred 
4 and MEMSAT-SVM online servers to assist in the identification of the transmembrane 
domains of the APOL1 channel. We then generated and purified 35 cysteine mutants of APOL1 




We performed our own in silico analysis of the full amino acid sequence of G0 APOL1 
(28-398) sans the signal peptide. The nine various online prediction servers utilize various 
methods to determine the secondary structure and potential transmembrane domains of the 
inputted amino acid sequence. After performing this meta-analysis, a total of four unique 
putative transmembrane domains were identified (Table 1). All nine servers predicted a 
transmembrane domain spanning residues 175-197 (TM1), while six out of the nine software 
programs identified a second putative transmembrane domain (TM2) located between amino 
acids 206-226. With a short span of residues between these two regions, TM1 and TM2 form a 
potential helix-loop-helix motif reminiscent of bacterial toxins. Interestingly, only the Jpred 4 
server identifies a potential transmembrane domain (TM3) spanning residues 264-282, which 
resides in the theoretical membrane-addressing domain (MAD). Finally, a fourth transmembrane 
(TM4) is positively predicted by seven of the nine software servers, and is located in the C-
terminus and thus the SRA-interacting domain (334-354) of the protein.  
Based on this data, we developed a consensus model of three predictive transmembrane 
domains for the APOL1 channel. Consisting of TM1, TM2 and TM4, in agreement with an 






between the extracellular or intracellular localization of the solvent accessible residues, so we 
cannot comment on the channel orientation at this time. Additionally, we want to highlight the 
four transmembrane and two transmembrane models predicted by Jpred 4 and MESAT-
SVM/DAS, respectively (Figure 27). This is due to the fact that of the well-studied ion channels, 
only the Ca2+ activated K+ channel has an odd number of transmembrane domains [108]. 
Therefore, we cannot immediately rule out the possibility of the four or two transmembrane 
models. 
With all three possible structure prediction models indicating numerous intracellular/trans 
residues, we wanted to confirm if this was indeed the case. Therefore, we tested the cis and trans 
effects of various proteases on the G0 rAPOL1 channel. After the protein was inserted into the 
membrane at acidic pH 5.4 and channels opened after subsequent neutralization to pH 7.4, 
proteinase K was added to the cis chamber (Figure 28). Cutting after hydrophobic residues, 
proteinase K caused an approximately 50% decrease in the macroscopic conductance, but the 
channel still retained pH gating functionality. After addition of proteinase K to the trans 
chamber, the conductance decreased once again, demonstrating amino acids involved in ion 
movement are undeniably located on the trans side of the membrane. However, we are unable to 
conclude the exact number or the precise function of the residues cleaved by proteinase K. 
The wide pH range of proteinase K activity, from pH 4-12, gives us the ability to test if 
additional sites are accessed when pH gating the channels [136]. APOL1 was inserted into the 
membrane with cis pH 5.4, forming a 4-5 pA current. A large molar excess of Proteinase K was 
added to the cis chamber for a specific activity of 1.8 mAU/mL (Figure 28B). After ~3 minutes, 
which should be sufficient time to cleave the ~9.3 pmol of protein, the channels were opened by 




suggesting APOL1 is protected from proteinase K activity once it has entered the membrane 
(Figure 28B). However, the conductance began to immediately decrease due to the activity of 
proteinase K still in the cis chamber. Thus, it would appear pH gating is not affected by 
proteinase K, and additional cleavage sites are accessible due to a conformational change when 
switching from acidic to neutral pH.  
While proteinase K activity had no effect on pH gating, it is unclear as to its effect on 
selectivity of the channel. We have previously shown in this dissertation that the channel cation 
selectivity responds to cis pH, but it is unknown if the filter is inside or outside of the membrane. 
If we consider cis addition of proteinase K causes a large decrease in conductance, it stands to 
reason the filter could be on the extracellular side of the membrane. To test this idea, G0 
rAPOL1 was added to the cis chamber and allowed to insert into the membrane at pH 5.4. After 
insertion, proteinase K was allowed to cleave any accessible amino acids residues at pH 5.4, 
before further digestion of the cis residues at neutral pH. After sufficient digestion, 3 M KCl was 
added to the cis chamber to create an ion gradient. At this activity raio of 1.78:1 cis to trans, the 
reversal potential of the system was determined to be approximately -16 mV on the cis side (data 
not shown). Using the Nernst equation, the reversal potential was calculated to be -16.5 mV, 
indicating the channel still appears to retain its ideal cation activity. 
Having sufficiently tested the effect of proteinase K on APOL1 channel characteristics, 
we wanted to test the effect of other proteases. After forming open channels, trypsin was added 
to the trans chamber, but unlike proteinase K there was no effect observed on macroscopic 
conductance (Figure 29). Trypsin was then added to the cis chamber, and again no effect on the 
conductance was measured. This could be explained by the high specificity of trypsin compared 




on the other hand, cuts after hydrophobic residues, but given sufficient time can reduce proteins 
to single amino acids [136]. To test that nothing was wrong with the system, pronase was added 
to both the cis and trans chambers, resulting in a similar effect of that seen for proteinase K 
(Figure 29).  
With sufficient evidence that the channel has residues involved in channel conductance 
on both faces of the membrane, we wanted to more precisely determine the membrane topology. 
To accomplish this, we utilized the scanning cysteine accessibility method on the entirety of the 
APOL1 protein. By introducing 35 individual cysteines at various locations into APOL1, which 
does not contain any intrinsic cysteine residues, we could precisely biotin label the protein with 
MPB (Figure 30 and 31). The maleimide group of the molecule reacts specifically with free 
thiols at neutral pH, and is linked to a biotin moiety (Figure 31A and B). If the protein were still 
trypanolytic in a 24-hour assay, it would be introduced into the bilayer system and probed with 
streptavidin for effects on the overall macroscopic conductance (Figure 31C). It would be 
assumed that whichever side the streptavidin was added to cause the effect was the location of 
the cysteine, and repeating for each purified cysteine APOL1 protein would yield the relative 
membrane topology.   
To begin purifying rAPOL1 proteins, 35 primer sets were generated to introduce cysteine 
substitutions throughout the APOL1 protein via PCR mutagenesis (see methods). With 
significant assistance from Penny Lee, each separate substitution was purified by first 
transforming the pNIC-28 plasmid containing the mutated APOL1 gene into specialized BL21-
DE3-RIPL cells. After isolation of the inclusion bodies, the rAPOL1 protein was purified as 










activity. Testing of the proteins revealed N-terminal cysteine mutations had minimal effect on 
activity (fig 27). Conversely, substitutions within the HLH caused complete loss of function of 
several proteins, defined here by less than 50% lytic activity at a final concentration of 800 
ng/mL (Figure 33A), only L158C, V168C and T217C retained any activity. Within the so-called 
MAD, only the L268C protein was non-functional (Figure 34A). In the C-terminal domain, 
V338C and D348C caused loss of activity (Figure 35A). This was unsurprising for the D348 
residue, considering it has a large role in pH gating and cation selectivity described in the first 
chapter, but may suggest V338C is part of the pore as well. These results have been summarized 
in Tables 2 and 3.  
The proteins that retained trypanolytic activity were subsequently conjugated with MPB, 
and then purified over a monomeric avidin column to remove unlabeled protein. After removal 
of free MPB and free biotin in the elution buffer with a spin column, the labeled protein was 
tested in a 24-hour assay. Interestingly, none of the N-terminal cysteine substitutions lost 
complete lytic activity when tagged with the MPB moiety (Figure 32B), strongly suggesting this 
region may not have any importance to the lytic activity of APOL1. However, tagging APOL1 
from L158C to I228C with MPB resulted in a non-functional protein, highlighting the 
importance of this region for trypanolytic activity (Fig 28B). Within the MAD, residues, L248C, 
L258C and L268C were all non-functional after tagging with MPB, hinting at an important 
domain in this region (Figure 34B). Additionally, MPB-H298C showed a lack of trypanolytic 
activity; however the reasoning is unclear. In the C-terminus, only the V346C protein lost 
functionality in this assay (Figure 35). These findings have been summarized in Tables 2 and 3. 
 To ensure we had efficient labeling of the cysteine proteins with MPB, we had to find a 






streptavidin prior to an SDS-PAGE gel under both reducing and non-reducing conditions. The 
streptavidin-biotin interaction has a Kd of approximately 10-15 M, and is one of the strongest non-
covalent interactions known [138]. Furthermore, the interaction can withstand up to 2% SDS, so 
any MPB tagged APOL1 would see a large shift in migration due to the addition of the ~53 kD 
Streptavidin tetramer [139]. Using ~0.94 uM APOL1 incubated briefly with 9.5 uM streptavidin, 
the samples were run on a Tris-glycine anyKD Bio rad gel. After coomassie staining, only a 
rAPOLl-sized band appeared in the G0 rAPOL1 lane, which does not have a cysteine or MPB 
tag (Figure 36A and B). On the other hand, all the tagged proteins had either faint or un-
detectable ~43 kD bands, implicating efficient labeling and purification of the MPB-APOL1 
proteins both with and without reducing conditions (Figure 36A and B).  
Now having confirmed which proteins are no longer trypanolytic and we had uniform 
labeling of the cysteine APOL1 proteins, we began testing them in the bilayer system. With 
streptavidin being a 52.9 kD protein (tetramer), we assumed it could block the steady-state 
conductance by either sterically blocking the pore or causing a deleterious conformational 
change due to its size. To avoid testing any non-conducting protein, only APOL1 cysteine 
mutants that retained lytic activity were chosen, because we expected them to still form channels 
in the bilayer system. We began with the viable MPB-V244C protein, which indeed generated a 
large conductance upon acidification and subsequent neutralization (Figure 37) While addition of 
streptavidin (~10-fold molar excess) to the trans chamber had no effect on the channel 
conductance, adding the same concentration of streptavidin to the cis chamber caused a large and 
rapid decrease in conductance (Fig 32). Therefore, we strongly infer the cysteine at position 244 
is on the cis/extracellular side of the membrane.  
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 We next tested the MPB-R305C protein, which is predicted to reside on the trans side of 
the membrane in both topology models. Expectedly, based on our trypanolytic assay results, the 
protein formed a large and stable conductance at neutral pH after insertion at pH 5.6 (Figure 38). 
However, streptavidin had no effect on the conductance of the system, even when adding 20-fold 
molar excess compared to MPB-R305C protein (190 nM Streptavidin compared to 9.4 nM 
APOL1) to both the cis and trans solutions. Based on this, we can infer the streptavidin was 
either unable to access the MPB residue because it was either not exposed to the aqueous buffer 
or the residue is located in a region not vital for channel function. On the other hand, streptavidin 
had a significant effect on the MPB-K373C channel when added to the cis chamber, but not the 
trans (Figure 39). Therefore, we can conclude this residue is on the cis/extracellular side of the 
bilayer as well. We went on and examined numerous other MPB-APOL1 proteins in the bilayer, 
but only the A108C showed any effect after streptavidin addition (Summary of Results in Table 
4).  
Based on the evidence here, the two (MEMSAT-SVM) and three (consensus) 
transmembrane models predicted by in silico analysis seem unlikely. However, we are unable to 
confirm the four transmembrane model at this time, although our data does support it. Therefore, 
we used Protter to generate a topology model and the effect of each cysteine substitution on each 
position (Figure 40). A green circle indicates no effect on lytic activity with or without MPB, so 
these regions may not have significant impact on channel formation. An orange circle indicates 
the cysteine substitution produced a lytic protein, but tagging with MPB caused complete loss of 
activity. A red circle indicates just a cysteine substitution cause loss of functionality in the 24-







In this section, we assess the membrane topology of the APOL1 channel. Secondary 
structure prediction servers Jpred 4 and MEMSAT-SVM estimated APOL1 had either four or 
two transmembrane domains, respectively. While a consensus of nine different transmembrane 
prediction servers identified three putative transmembrane domains. We next assessed if APOL1 
channels in the planar lipid bilayer system were affected by protease digestion on either the cis or 
trans side of the membrane. Indeed, proteinase K and pronase caused significant reductions in 
macroscopic conductance after addition to the cis or trans chambers, signifying the channel must 
have residues on the extracellular and intracellular sides. Interestingly, trypsin had no effect on 
APOL1 channel conductance possibly due to its inability to cleave between any residues in the 
HLH of APOL1. To better confirm membrane topology, we generated and purified 35 different 
cysteine substitutions of APOL1 to employ the scanning cysteine accessibility method. Testing 
each mutant with and without MPB labeling in 24-hour Trypanolytic assays identified residues 
that retained functionality, which could then be tested in the planar lipid bilayer system. Of all 
the proteins tested, addition of streptavidin to the cis chamber, but not the trans, was able to 
significantly lower conductance of the only MPB-A108C, V244C and K373C proteins. Thus, it 
appears these residues are located on the extracellular side of the membrane, supporting a four 
transmembrane model of APOL1. 
An in silico approach was utilized to identify potential transmembrane models we could 
begin to test in vitro. The first sever we employed, Jpred 4, predicts four transmembrane 
domains; an N-terminal HLH (residues 177-228) forms TM 1 and 2, while the third 




356, which is most likely the pore-lining region we examined earlier. While we only were able to 
correctly identify three residues that were located on the extracellular side of the membrane, they  
all confer with the Jpred 4 prediction. Additionally, each of the four predicted transmembrane 
domains were intolerant to cysteine substitution (red circle), which may further support this 
model (Figure 40). Assuming this model is correct, the APOL1 channel could have a similar 
conformation to that of the human voltage proton channel (HVCN1) [140]. Notably, the HVCN1 
channel has four transmembrane domains and a C-terminal heptad repeat allowing for channel 
dimerization. This alone makes it a great candidate as a similar protein for future modeling, not 
to mention the channel relies on an aspartic acid as the selectivity filter [141]. But without 
further evidence of residues located on the trans portion of the membrane in the bilayer system, 
we cannot confirm this suspicion.  
The second prediction software, MEMSAT-SVM predicted regions 177-197 and 335-356 
as pore lining transmembranes. Interestingly, these domains map to TM1 and TM4 of the Jpred 4 
server, and data from Chapter 1 supports that the residues from 335-356 contribute to the channel 
selectivity. However, the data presented here seem to demonstrate the overall model incorrect. A 
large portion of the protein was predicted to be on the trans side of the membrane, including the 
V244 residue, which we determined to be exposed to the cis solution. Regarding other prediction 
models, a paper published in 2014 predicted APOL1 had three transmembranes using the 
PROFSec online software [14]. We know this cannot be possible because the K373C residue is 
extracellular (Figure 39), and only three transmembranes would position the residue on the 
cytoplasmic side. However, it is interesting to note that all three different software programs 
predicted TMs at regions 177-197 and 335-356, althoug it is most likely due to the high degree 




predicted by software is that only the HLH of APOL1 inserts into the membrane. This overall 
structure would be similar to the Salmonella enterica CorA channel, which has a helix loop helix 
that inserts into the membrane and the remainder of the channel is found in the extracellular 
milleu [142]. Considering MPB conjugated to APOL1 cysteine groups in the HLH region caused 
complete loss of activity, we suspect this region may indeed insert into the membrane. If the 
remainder of the protein was then not in the membrane, this would agree with our assessment 
that residues A108, V244 and K373 are all on the extracellular side of the membrane. 
Additionally, the CorA channels have a ring of aspartic acid residues that control selectivity of 
the divalent cations [142]. But this region exists outside of the membrane, and proteinase K did 
not affect APOL1 selectivity. If the selectivity filter was removed, we should have seen a change 
in the reversal potential toward anion selectivity.  
Therefore, we speculated if it is possible the residues from 335-356 form an 
intramembrane loop similar to the inward rectifying potassium channels [143]. For this family of 
channels, each subunit contributes two transmembranes that form the channel through the 
membrane and a pore loop that acts as the selectivity filter. For APOL1, the HLH would supply 
the transmembrane portion, while domain from 335-356 would act as the selectivity filter. The 
topology would satisfy the cis location of the A108, V244 and K373 residues, and allow for 
asparate-348 to be in the membrane and protected from proteases. However, it should be noted 
that transmembrane domains often directly flank the intramembrane loop in the major ion 
channel families [144]. Therefore, it seems unlikely APOL1 assumes this conformation, but it is 
possible the channel has a structure unprecedented in the literature. 
Other groups attempting to determine the membrane topology and structure have had 




protein has five transmembrane domains [81]. Interestingly, they predicted the HLH of APOL1 
(171-221) as TM2 and TM3, with an N-terminal TM1 spanning residues 35-64. However, we do 
not have any data to support this observation, since probing this region with streptavidin in the 
bilayer had no effect on channel conductance. The fourth predicted transmembrane is roughly 
near our observed pore-lining region we focused on earlier, but they did not observe the D348 
residue was in the pore [81]. Additionally, they predicted the C-terminal coiled-coil is in the 
membrane, which is unlikely because this region both binds to SRA and the MPB labeled K373C 
within this region is accessible by the large streptavidin molecule. They also propose a pH-gating 
residue E355, characterized by Russell Thomson (unpublished) to be near the trans side of the 
membrane, which would prevent the amino acid from responding to changes in cis pH. We 
therefore conclude the model they have published does not accurately depict the APOL1 
channel.  
 Curiously, trypsin appears unable to alter the macroscopic conductance of APOL1 
channels once in the membrane. Addition of trypsin to both chambers had no effect, while 
pronase quickly and significantly reduced channel conductance in the same experiment. Because 
trypsin only cuts after arginine and lysine residues, we would predict they are either inaccessible 
because they are either buried within the membrane or the core of the quaternary protein 
structure. Looking at the protein sequence, there are numerous predicted cut sites on the putative 
extracellular and intracellular regions. We have tested that trypsin can indeed hydrolyze APOL1 
when added to soluble protein (data not shown), so this non-effect must be intrinsic to the 










 In this thesis, we have thoroughly examined the APOL1 channel using a combination of 
site directed mutagenesis, in vitro trypanolytic assays and planar lipid bilayers. Prior to the work 
presented here, the pore-forming domain of APOL1 was understood to be in the N-terminal 
domain, and the C-terminus was thought to be dispensable for both channel and trypanolytic 
activity. Rather, our data conclude the C-terminus is required for multimerization by way of a 
coiled-coil to form the functional channel. Additionally, the pore lining region and selectivity 
filter, aspartate-348, reside in the C-terminal domain. We also have preliminary data suggesting 
the channel is a four pass transmembrane protein, with a N-terminal hairpin motif crucial to 
membrane insertion. Taken together, identification of these structural domains will assist to 













Appendix 1 – Purification of recombinant APOL1 from E. coli 
 
Prepare all solutions using ultrapure water and analytical grade reagents. All steps should be 
carried out at room temperature unless otherwise noted. Diligently follow all waste disposal 
regulations when disposing of waste materials. 
 
Buffer solutions 
1. Lysis buffer: 50mM Tris-HCl, 1mM EDTA, pH 8.0. Weigh 3.03g of Tris base and add to 
400mL of DI water in a 500mL graduate cylinder. Add 1mL of 0.5M EDTA, mix well, and pH 
solution to 8.0. Make up to 500mL with DI water. Can be stored at room temperature. 
2. 10% sodium deoxycholate: Add 0.3mg of powdered sodium deoxycholate to 2mL of DI water 
in a 15mL tube. Vortex to mix, then fill to 3mL and vortex again. Solution must be made fresh 
and cannot be stored for subsequent purifications. 
3. 1:5 diluted lysis buffer: Add 100mL of lysis buffer to 400mL of DI water in a graduated 
cylinder and mix well. Can be stored at room temperature. 
4. 10% Zwittergent 3-14: Add 4g of powdered detergent to 30mL of DI water in a 50mL falcon 
tube. Vortex to mix, and fill to 40mL. Zwittergent solution can be stored at 4°C. (see Note 1) 
5. 10% Triton X-100: 10% solution in DI water (see Note 2) 
6. Zwittergent running buffer: 50mM Tris-HCl, 150mM NaCl, 0.5% Zwittergent 3-14, pH 8.6. 
Weigh 3.03g of Tris-Base and 4.4g of NaCl. Add to 400mL of DI water in a graduated cylinder. 
Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L. Sterilize with a 0.22um filter, 
and then degas under vacuum for ~20 minutes. Carefully add 2.5g of Zwittergent 3-14, and stir 
gently until all detergent has dissolved into solution. (see Note 1) 
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7. Wash buffer: 50mM Tris-HCl, pH 8.6, 150mM NaCl, 10 mM Imidazole, 0.5% Zwittergent 3-
14. Weigh 3.03g of Tris-Base, 4.4g of NaCl, and 340mg of Imidazole. Add to 400mL of DI 
water in a graduated cylinder. Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L. 
Sterilize with a 0.22um filter, then add 2.5g of Zwittergent 3-14, and stir gently until all 
detergent has dissolved into solution. (see Note 1) 
8. Elution buffer: 50mM Tris-HCl pH 8.6, 150mM NaCl, 500mM Imidazole, 0.5% Zwittergent 
3-14. Weigh 3.03g of Tris-Base, 4.4g of NaCl, and 17.02g of Imidazole. Add to 400mL of DI 
water in a graduated cylinder. Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L. 
Sterilize with a 0.22um filter, then add 2.5g of Zwittergent 3-14, and stir gently until all 
detergent has dissolved into solution. (see Note 1) 
9. n-Dodecyl β-D-maltoside (DDM) running buffer: 50mM Tris-HCl, 150mM NaCl, 0.05% 
DDM, pH 8.6. Weigh 3.03g of Tris-Base and 4.4g of NaCl. Add to 400mL of DI water in a 
graduated cylinder. Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L. Sterilize 
with a 0.22um filter, and then degas under vacuum for ~20 minutes. Carefully add 0.25g of 
DDM, and stir gently until all detergent has dissolved into solution. (see Note 1) 
 
Equipment 
1: 37°C water bath. 
2: Temperature controlled orbital shaker 
3: Sonic Dismembrator apparatus with microtip probe 
4: Sorvall RC-5C Plus Centrifuge (or comparable centrifuge) 
5: Sorvall GSA 6 place rotor (or comparable rotor) 
6: Sorvall SS-34 rotor (or comparable rotor) 
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7: Beckman Coulter Type 60 Ti Fixed-Angle Titanium Rotor (or comparable rotor) 
8: Polycarbonate bottle with cap assembly 25 x 89mm (Cat# 355618) 
9: Fast-performance liquid chromatography apparatus. 
10: GE HiLoad 16/600 Superdex 200 pg size exclusion column (or comparable column) 
11: GE HisTrap HP protein purification column (Cat# 17524701) 
12: Amicon Ultra-15 Centrifugal Filters 10,000 Dalton molecular weight cutoff (Fisher Cat# 
UFC901024). 
Transformation of bacteria with APOL1 plasmid 
Day 1 
1. Bacterial expression cells: Add 10-50ng of purified pNIC plasmid containing the APOL1 
coding sequence to 50uL of Bl21-DE3-RIPL cells under sterile conditions in a 13mL polystyrene 
tube. Flick gently to mix, then let sit on ice for 30 minutes. (see Note 3) 
2. Heat shock for 23 seconds at 42*C and place back on ice for 4 minutes. Add 500uL of pre-
warmed LB media to tube and shake for 1 hour at 37*C at 300rpm.  
3. Plate 500uL of bacterial culture on Luria Bertani agar supplemented with kanamycin and 
incubate overnight at 37*C. 
Bacterial Growth and Protein Expression 
Day 2 
1. Prepare 200mL of Overnight Express Growth media in a 500mL bottle and microwave with 
the cap loose until a slight boil to sterilize. Let cool, and add Kanamycin (100ug/mL) and 
Chloramphenicol (34ug/mL) and mix well. Transfer 100mL of media into a 1L Erlenmeyer 
flasks under sterile conditions. 
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2. Examining the plates from yesterday, select 1-5 colonies and add to the flask under sterile 
conditions. Let shake for 16-18 hours overnight at 37*C at 300rpm. There is no need for addition 
of IPTG with this protocol. (see Note 4) 
 
3.2.3.Isolation of Inclusion Bodies 
Day 3 
1. Centrifuge the bacterial millieau at 6000 x g for 15 minutes in a GSA rotor at 4*C. 
2. On ice, resuspend in 18 mL of lysis buffer and transfer to an SS34 tube (rounded cylinder). 
Add 10uL 1 M DTT and 50uL 200 mM PMSF. Lyse cells via microtip sonication using a 2 
second pulse at a 40% duty cycle set to the microtip limit. Sonicate on ice for 1 minute, then let 
stand on ice for 1 minute. Repeat three times. (see Note 5) 
3. At room temperature, while stirring, add 20uL of 5mg/mL DNase1, 20uL 5 mg/mL RNase1, 
and 100uL 50 mg/mL lysozyme. Stir for 45 minutes. Then add 70uL 1M MgCl2 and 40uL 1 M 
CaCl2 and stir for 30 minutes. Finally, add 1mL 10% Triton X-100 and 1 mL 10% sodium 
deoxycholate (make fresh) and stir for 1 hour. 
4. Remove stir bars, and pellet at 26,000 x g (14.8k rpm in SS34 or F21S-8x50Y) for 30 minutes. 
5. Discard supernatant and resuspend pellet in 9 mL lysis buffer. While stirring, add 1 mL 10% 
Triton X-100 and 0.2 mL 5 M NaCl and stir for 30 minutes. 
6. Pellet at 17050 x g (12,000 rpm) for 30 minutes in an SS34 rotor. 
7. Discard supernatant and resuspend pellet in 10 mL lysis buffer. While stirring, add 0.2 mL 5 
M NaCl. Put sample(s) back on ice, remove stir bars, and repeat sonication according to the 
procedure in step 4.  
[At this point, sample(s) can be stored overnight at 4*C] (see Note 6) 
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8. Repeat centrifugation according to step 11. 
9. Discard supernatant and resuspend pellet in 10 mL of 1:5 diluted lysis buffer. 
10. Repeat centrifugation according to step 11. 
 
Extraction of rAPOL1 from inclusion bodies 
Day 3 
1. Discard supernatant and resuspend pellet in 8 ml DI water. Sonicate for a continuous ~10 
seconds to disperse. While stirring, add 2 mL 10% Zwittergent 3-14. Slowly add 100 λ 1 M 
NaOH (see Note 7). Wait 1 minute, and add 300 λ 5 M NaCl. Wait 1 minute, and slowly add 150 
λ 1 M Tris-HCl pH 7.4. Stir for 15-30 minutes. (see Note 8) 
2. Ultracentrifuge at 45,000 rpm (207,870 x g) for 45 minutes in a Ti70 rotor. Filter supernatant 
using a 0.45 micron filter. (see Note 9) 
[At this point, sample(s) can be stored overnight at 4*C] (see Note 10) 
 
Fast Protein Liquid Chromatography 
Day 4 
1. Concentrate sample down to ~5mL with a centrifugal filter unit. The MW cutoff of the filter 
should be 10,000 Daltons to ensure rAPOL1 (~43kDa) remains in the concentrated portion.  
Optional. (ideal if highly pure yields are required). Concentrate sample down further to ~2mL. 
Load the sample onto Superdex 200 16/600 column that has been equilibrated with Zwittergent 
running buffer. With the flow set to 1mL/min, collect 1mL fractions and keep tubes 45-80. 
APOL1 should elute around fraction ~65mL (see Note 11) 
	116	
Optional. Run SDS-PAGE of the fractions corresponding to the anticipated APOL1 peak, and 3-
4 fractions before and after. Add 1uL of each fraction to 19uL of 2X laemelli sample buffer. 
Load 15uL per lane and run at 150V. Coomassie stain and collect fractions with ideal ratios of 
rAPOL1 to contaminating bands. Collect no more than 5 fractions (Note 12). 
2. Load ≤5mL of sample to a 1mL His-Trap column. Program for a 1mL/min flow rate and load 
sample onto the column. Wash column with 15 CV of wash buffer, then increase concentration 
of elution buffer from 0% to 60% over 20mL. The rAPOL1 should elute during the gradient (see 
Note 13). After the gradient, clean the column with 5mL of 100% elution buffer and then 
equilibrate with 5mL of wash buffer. Collect 1mL fractions, beginning with the unbound fraction 
that immediately elutes up until the cleaning step. 
3. Run SDS-PAGE of the fractions corresponding to the anticipated APOL1 peak, and 3-4 
fractions before and after. Add 1uL of each fraction to 19uL of 2X laemelli sample buffer. Load 
15uL per lane, and run at 150V. Coomassie stain and collect fractions with ideal ratios of 
rAPOL1 to contaminating bands. Collect no more than 5 fractions (Note 12). 
4. Concentrate sample down to ~2mL with a centrifugal filter unit. The MW cutoff of the filter 
should be 10,000 Daltons to ensure rAPOL1(~43 kDa) remains in the concentrated portion..  
5. Using an equilibrated Superdex 200 16/600 column with DDM running buffer (see Note 14), 
load sample into an FPLC. Using DDM running buffer, flow at 1mL/min, collect 1mL fractions, 
and keep fractions 45-80mL. APOL1 should elute around fraction ~67mL. 
6. Run SDS-PAGE of the fractions corresponding to the anticipated APOL1 peak, and 3-4 
fractions before and after. Add 1uL of each fraction to 19uL of 2X laemelli sample buffer. Load 
15uL per lane, and run at 150V. Coomassie stain and collect fractions with ideal ratios of 
rAPOL1 to contaminating bands (Note 12).  
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7. Pool 2-3 fractions with ideal ratios of rAPOL1 to contaminant bands. Mix gently by flicking 
or slow pipetting up and down. Aliquot into ~100uL fractions, and flash freeze with liquid 
nitrogen before storage at -80*C. 
Notes 
1. Wear a mask and goggles when weighing out either Zwittergent 3-14 or DDM. Both 
detergents can be upper respiratory or eye irritants. 
2. Surfact-Amps Triton X-100 is purchased from Thermo Scientific (Product #28314).  
3. The rAPOL1 coding sequence contains a N-terminal 6X-His-Tag followed by a TEV cleavage 
site. The tag allows for metal affinity purification, but can be cleaved off before beginning 
experiments. 
4. In the event of a poor transformation efficiency, only one colony may be used for inoculation. 
However, several colonies help to ensure high bacterial growth and turbidity, along with high 
protein yields. 
5. When working with two tubes, both can be brought to sonication simultaneously. While one 
tube is being sonicated, the other can be standing. However, you must clean the microtip 
between sonicating if two different proteins are being purified at once.  
6. If time is a concern, the purification can be paused here until the following day. But note that 
storage overnight may cause proteolysis of rAPOL1 that is difficult to remove in subsequent 
steps. For high purity yields, it is best to continue up until step 17. 
7. On occasion, the solution will not go entirely clear at this point. Either there was too much 
rAPOL1 recovered, or the inclusion bodies were not solubilized because pH 12 was not reached. 
Check the pH of your solution if this is the case. 
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8. Adding the 1M Tris-HCl too quickly may cause the rAPOL1 to precipitate and fall out of 
solution. Slowly adding and allowing the Tris-HCl to bring the pH down in a controlled manner 
will yield the highest amount of solubilized rAPOL1. 
9. A Ti60 rotor may also be used. 
10. It is best to pause the purification here. However, the remaining steps must be completed the 
following day for optimal purity and yield. 
11. If running this additional purification step, it is important to equilibrate the column overnight 
from day 2 to day 3. This will save time on day 4. Run 2 column volumes of DDM size buffer 
through the column at 0.4mL/min. 
12. The lower, contaminating bands are often APOL1 that has been degraded by proteases during 
the purification process. They are difficult to remove, and every precaution must be made when 
selecting fractions to avoid them. For high purity yields, it is best to choose only 1-2 ideal 
fractions rather than 4-5. Ideal fractions will have the highest ratio of full length rAPOL1 to 
contaminating bands. 
13. Often, there will be a double peak during the gradient. The second peak contains rAPOL1 
aggregates that require additional imidazole to remove from the His-column. Try to avoid 
collecting and pooling any of these fractions before loading onto the final sizing column. 
14. If running the optional Zwittergent sizing column, the column must be equilibrated before 
beginning step 19. Run 2 column volumes of DDM running buffer through the column at 
1mL/min. If not performing the optional sizing step, the column may be equilibrated overnight 
with DDM running buffer between days 2 and 3 at a rate of 0.4mL/min. 
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